Find out who has spoken at Galien Forums and Events

	NAME	COMPANY	TITLE	EVENT	TOPIC
2022	Juan Camilo Arjona Ferreira	Myovant Sciences	CMO	Galien Week of Innovation	Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2022	Javier Boix	Novartis	Global Head, Communications & Engagement, Novartis Pharmaceuticals	Galien Webinars Series	Golden Jubilee - Best Pharmaceutical Category
2020	Jeremy Abbate	Scientific American	Vice President & Publisher	Jerusalem Ethics Forum	Tracking bioethics: transparency, trust & the industry’s social imperatives
2018	Salim Abdool Karim	Columbia University	Professor	Galien Forum Africa	managing infectious diseases & pandemics
2018	Salim Abdool Karim	Columbia University	Professor for Global Health	Galien Forum Africa	Remarkable women engage for humanity
2018	Papa Abdoulaye Seck	Senegal	Minister of Agriculture	Galien Forum Africa	Addressing chronic malnutrition
2020	Amy Abernethy	FDA	Principal Deputy Commissioner	Galien Webinars Series	Digital health improving research & care
2021	Imodoye Abioro	Healthbotics	Chief Executive Officer	Galien Forum Africa	Leadership & innovation, meet the winners of the africa young innovators award for health
2018	Anna K. Abram	FDA	Deputy Commissioner for Policy, Planning, Legislation & Analysis.	Galien Forum USA	Keynote
2022	Michael D. Abramoff	Digital Diagnostics Inc	Digital Diagnostics	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Paul Adam	Boehringer	Head Cancer Immuno MOD	Galien Week of Innovation	Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence
2018	Isaac Adewole	Nigeria	Minister of Health	Galien Forum Africa	Which plan for non communicable diseases?
2021	Nanahemaa Adjoa Awindor	Development Queenmother Afigya-Kwabre District – Ghana	Professor	Galien Forum Africa	Women’s leadership in global health security
2021	Desmond Adler	Glaukos Corporation	General Manager & Vice President R&D, Corneal Health	Galien Week of innovation	What is med tech innovation doing for patients with specialized needs for treatment?
2018	Sultana Afdhal	WISH, Qatar	Chief Executive Officer	Galien Forum Africa	Plenary Panel - women in stem in africa
2014	Mohammad Afshar	Ariana pharma	CEO	Galien Foum Monaco	Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021	Shefali Agarwal	Epizyme	Chief Medical & Development Officer & trained medical oncologist	Galien Week of innovation	Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2018	Cinzia Akbaraly	Akbaraly Foundation - Madagascar	Founder & President	Galien Forum Africa	Plenary Panel - women in stem in africa
2022	Sarah Akerman	Alkermes, Inc	Executive Medical Director	Galien Week of Innovation	Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2018	Sarah Akerman	Alkermes	Senior Medical Director	Galien Forum USA	Novel approaches to combatting opioid addiction
2021	Bola Akinlade	Regeneron	Vice President, Clinical Sciences, Immunology & Inflammation	Galien Week of innovation	Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions?
2021	Chrispin Akuzwe	Patient Monitoring System – Rwanda	Smart Chair	Galien Forum Africa	Meeting of young innovators with investors
2021	David E. Albert	AliveCor Inc.	Founder & Chief Medical Officer	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2016	Charles Albright	Editas	Journalist	Galien Forum USA	Molecular scissors: what can we expect from gene editing?
2022	Alexey Aleshin	Natera, Inc.	MD, MBA	Galien Week of Innovation	Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2022	Sally Allain	Johnson & Johnson Innovation, LLC	Head of Innovation	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2013	David Altshuler	Massachusetts General Hospital & Broad Institute	Professor	Galien Forum USA	Personalized medicine: effect on drug r&d & patient care
2021	Yele Aluko	EY Americas Business Consulting Health Sector	Chief Medical Officer	Jerusalem Ethics Forum	Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2021	Pape Amadou Sarr	Delegation à l’Entreprenariat Rapid– Senegal	Director General	Galien Forum Africa	Meeting of young innovators with investors
2021	Samuel Amo Tobbin	TOBINCO Group of Companies – Ghana	Executive Director	Galien Forum Africa	Meeting of young innovators with investors
2021	Samuel Amo Tobbin	TOBINCO Group of Companies – Ghana	Executive Director	Galien Forum Africa	Closing ceremony
2022	Aseem Anand	Lantheus	VP Digi Imaging Biomarkers Lantheus	Galien Week of Innovation	Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2022	David E. Anderson	VBI Vaccines Inc.	Chief Scientific Officer	Galien Week of Innovation	Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2022	Emily Anderson	Boston Scientific Corp.	Director, Global Corporate Communications	Galien Webinars Series	Golden Jubilee - Best MedTech Category
2014	David J. Anderson	Howard Hughes Medical Institute, California Institute of Technology	Seymour Benzer Professor of Biology,	Galien Forum USA	The brain initiative
2018	John Andrianarisata	Benin Country Office African Development Bank	Country Manager	Galien Forum Africa	Addressing chronic malnutrition
2021	Mert Aral	Huma	Head of R&D & Clinical Strategy	Galien Week of innovation	Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2021	Juan Camilo Arjona Ferreira	Myovant Sciences Ltd., Myovant Sciences, Inc.	Chief Medical Officer	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2022	Katrina Armstrong	Faculties of health sciences and the Vagelos college of physicians and surgeons & Columbia university Irving medical center Harold and Margaret hatch professor in the faculty of medicine	Executive vice president for health and biomedical sciences - Dean & CEO	Galien Forum USA - Chair	Diversity and health equity in the future creation of medicine
2021	Scott A. Armstrong	Dana-Farber Cancer Institute	President, Boston Children’s Cancer & Blood Disorders Center; Chairman, Department of Pediatric Oncology,	Galien Forum USA	New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2015	David Artis	Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medical College Cornell University, Joan & Sanford I. Weill	Michael Kors Professor of Immunology Director, Department of Medicine	Galien Forum USA	Microbiota in human diseases
2021	El Hadji As Sy	Kofi Annan Foundation International – Senegal	President	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2018	El Hadji As Sy	International Federation of Red Cross & Red Crescent Societies	Secretary General	Galien Forum Africa	Financing africa’s healthcare
2022	Simon Ashwell	GSK	Global Corporate Affairs and Sustainability	Galien Webinars Series	Golden Jubilee - Best Vaccine Category
2020	Paul Atlan	University Paris-Descartes, France	Director of Teaching of Transcultural Biomedical Ethics	Jerusalem Ethics Forum	Up-to-date reflection on society, medicine & reproduction
2019	Paul Atlan	University Paris-Descartes, France	Director of Teaching of Transcultural Biomedical Ethics	Jerusalem Ethics Forum	Personalized genomics medicine: the value of knowing
2013	Christopher Austin	National Center for Advancing Translational Sciences, National Institutes of Health	Director	Galien Forum USA	The promise of gene therapy
2015	Richard Axel	the Kavli Institute for Brain Science, Columbia University Medical Center, New York	Nobel Laureate, Co-Director	Galien Forum USA	Untangling the web of neurodegeneration: how far & how soon?
2014	Richard Axel	the Kavli Institute for Brain Science, Columbia University Medical Centre, New York	Nobel Laureate, Co-Director	Galien Forum USA	The brain initiative
2021	Maëlle Ba	Speak Up Africa	Strategic Communications Manager,	Galien Forum Africa	Leadership & innovation, meet the winners of the africa young innovators award for health
2021	Doudou Ba	Academy of Sciences & Techniques of Senegal	President	Galien Forum Africa	Conference on reform in health training
2021	Mamadou Ba	Leadership & Management – Senegal	Institutional Capacity Building Advisor	Galien Forum Africa	Youth leadership training (part 1)
2021	Mamadou Ba	Leadership & Management – Senegal	Institutional Capacity Building Advisor	Galien Forum Africa	Youth leadership training
2020	Alassane Ba	Humanitarian Center for Pharmacy Trades (CHMP France)	Director	Galien Forum Africa	Covid 19 drug supply chain in africa: challenges & perspectives
2015	Peter Bach	Center for Health Policy & Outcomes, Memorial Sloan-Kettering Cancer Center	Director	Galien Forum USA	Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2020	Junaid Bajwa	Microsoft	Chief Medical Scientist	Galien Webinars Series	Digital health in the aftermath of covid-19
2014	Andre-Michel Ballester	Sorin group	CEO	Galien Foum Monaco	Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021	Jeffrey Balser	Vanderbilt University Medical Center	President & Chief Executive Officer	Galien Webinars Series	The incubators of innovation: academic medical centers as digital health champions
2021	Stephane Bancel	Moderna	Chief Executive Officer	Galien Forum USA	Covid-19 vaccine development & the enduring impact on life sciences innovation – speed, collaboration, clinical trial advancement & manufacturing
2020	Stephane Bancel	Moderna	Chief Executive Officer	Galien Forum USA	Covid-19 vaccines: the path to the holy grail
2014	Cori Bargmann	The Rockefeller University, New York	Professor	Galien Forum USA	Keynote: fixed circuits & flexible behaviors
2022	Eliav Barr	Merck research laboratories	head, global clinical development & chief medical officer,	Galien Forum USA	Diversity and health equity in the future creation of medicine
2018	Françoise Barre-Sinoussi	Director of the Regulation Retroviral Infections Division Professor Institut Pasteur Paris, France	Nobel Prize for Medicine	Galien Forum Africa	Remarkable women engage for humanity
2018	Françoise Barre-Sinoussi	Institut Pasteur - France	Nobel Prize for Medicine	Galien Forum Africa	Plenary Panel - women in stem in africa
2018	Françoise Barre-Sinoussi	Institut Pasteur - France	Nobel Prize for Medicine	Galien Forum Africa	managing infectious diseases & pandemics
2021	Danny Bar-Zohar	Merck KGaA	Global Head of Development	Galien Forum USA	New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2017	Jose Baselga	Memorial Sloan Kettering Cancer Center GRAIL, Inc.	Physician-in-Chief & Chief Medical Officer, Director, Board of Directors,	Galien Forum USA	Addressing unmet medical needs with early-stage life science venture capital
2021	Gil Bashe	Finn Partners	Managing Partner, Chair Global Health	Galien Week of innovation	With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2021	Gil Bashe	Finn Partners	Managing Partner, Chair Global Health	Galien Webinars Series	The incubators of innovation: academic medical centers as digital health champions
2021	Gil Bashe	Finn Partners	Managing Partner, Chair Global Health	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021	Gil Bashe	Finn Partners	Managing Partner, Chair Global Health	Galien Webinars Series	Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020	Gil Bashe	Finn Partners	Managing Partner, Chair Global Health	Galien Webinars Series	The digital health enterprise: start-up trends & the culture of big pharma
2020	Gil Bashe	Finn Partners	Managing Partner, Chair Global Health	Galien Webinars Series	Digital health webinar – presentation of the nominees in the 2020 prix galien digital health category
2020	Gil Bashe	Finn Partners	Managing Partner, Chair Global Health	Galien Webinars Series	Digital health in the aftermath of covid-19
2022	Gil Bashe	Finn	Chair Glob. Health&Purp. Moderator:	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020	Emmanuel Bassene	Ministry of Health & Social Action (Senegal)	Associate of Pharmacognosy & Head of the Traditional Medicine Division	Galien Forum Africa	Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5:
2020	Nathan Belete	Senegal, Mauritania, Guinea Bissau, Gambia & Republic of Cape Verde, World Bank	Director of Operations	Galien Forum Africa	Socio-economic impact of the covid 19 pandemic sub-theme 3
2021	Karim Bendhaou	IFPMA	Representative	Galien Forum Africa	Leadership & innovation, meet the winners of the africa young innovators award for health
2021	Christoph Benn	Global Health Diplomacy	Director	Galien Forum Africa	Innovations & ethic for global health security
2015	Frank Bennett	Ionis Pharmaceuticals	Senior Vice-President of Research,	Galien Forum USA	Spinal muscular atrophy: charting the pathway to clinical progress
2019	Zion Ben-Rafael	Rabin Maj Center’s Campus Beilinson & Golda, Israel	Director of the Department of Obstetrics & Gynecology	Jerusalem Ethics Forum	Human reproduction: technical limit, ethical limit
2020	Bjarne Bergheim	Sonendo, Inc	President & Chief Executive Officer	Galien Week of innovation	What is medtech innovation doing for patients with specialized needs for treatment?
2011	Jeffrey Berkowitz	Walgreens	Senior Vice President Pharmaceutical Development & Market Access	Galien Forum USA	What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2014	Emily Bernstein	Icahn School of Medicine at Mount Sinai	Prize Winner & Associate Professor of Oncological Sciences & Dermatology,	Galien Forum USA	Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2021	Rachele Berria	AstraZenica	Vice President & Medical Heads US Biopharmaceuticals	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 2
2021	Rachele Berria	AstraZenica US	Vice President & Medical Head	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19
2020	Uri Bettesh	Datos-Health	Chief Executive Officer	Galien Webinars Series	Digital health in the aftermath of covid-19
2020	Sailaja Bhaskar	Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P.	Executive Director, Clinical Operations Planning	Galien Week of innovation	The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2022	Sangeeta Bhorade	Natera, Inc.	CMO, Organ Health Division	Galien Week of Innovation	Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2020	Satasuk Joy Bhosai	Duke Clinical Research Institute	Chief of Digital Health & Strategy	Galien Webinars Series	Digital health improving research & care
2014	Francis Bidault	Esmt European Xchool of Management and Technology	Professor	Galien Foum Monaco	Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021	Agnes Binagwaho	Global Health Equity University, The Global Health Equity University, Former Minister of Health of Rwanda	Chancellor	Galien Forum Africa	Conference on reform in health training
2021	Agnes Binagwaho	Global Health Equity University, Former Minister of Health of Rwanda	Chancellor	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020	Fatou Binetou Sarr	UFR Thies; Laureate of the Macky SALL Gr& Prize for Innovation (Senegal)	Teacher & Researcher	Galien Forum Africa	Place of women in innovation related to covid 19 sub-theme 2:
2018	Kathie M. Bishop	Otonomy	Chief Executive Officer	Galien Forum USA	Spinal muscular atrophy: charting the pathway to clinical progress
2022	Andy Blackwell	Ieso Digital Health	Chief Science & Strategy Officer	Galien Forum UK	Digital health innovation: a key driver of next generation healthcare – what & when?
2015	Cheryl R. Blanchard	Microchips Biotech, Inc.	Chief Executive Officer	Galien Forum USA	Us health reform: partnering, pricing & politics
2015	Cheryl R. Blanchard	Microchips Biotech, Inc.	Chief Executive Officer	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2022	Robert O. Blaustein	Merck & Co., Inc	AVP Global Clinical Devt	Galien Week of Innovation	Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2017	Carina Blomström-Lundqvist	Uppsala University	Professor of Cardiology	Galien Forum USA	Atrial fibrillation
2014	Jeff Bluestone	Provost at UCSF	Immunology & Head of the Diabetes Center,	Galien Forum USA	Cancer immunotherapeutics
2021	Boris Bogdan	Accenture	Global Lead Medical	Galien Week of innovation	What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2022	François-Henri Boissel	Novadiscovery	Cofounder CEO Novadiscovery	Galien Week of Innovation	Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2016	Michael W. Bonney	Cubist Pharmaceuticals Inc.; Advisor, UK Review on Antimicrobial Resistance	Retired Chief Executive Officer,	Galien Forum USA	Next generation antimicrobials – shaping policy to develop new business models
2022	Marc Bonten	Royal Netherlands Academy of Arts and Sciences (KNAW)	Professor	Galien Forum Netherlands	#VALUE!
2018	Alexis Borisy	Third Rock Ventures	Partner	Galien Forum USA	Cancer in a time of disruption
2015	Alexis Borisy	Third Rock Ventures	Partner	Galien Forum USA	Autism - the next decade
2021	Ouided Bouchamaoui	Tunisian Union of Industry, Commerce & Handicrafts	Peace Nobel Prize	Galien Forum Africa	Socio-economic consequences, equity & gender in the global health security
2021	Ouided Bouchamaoui	Honorary Committee of the Prix Galien Afrique	Nobel Prize for Peace	Galien Forum Africa	Closing ceremony
2020	Ouided Bouchamaoui	Tunisian Union of Industry, Commerce & Handicrafts	Peace Nobel Prize	Galien Forum Africa	Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2018	Ouided Bouchamaoui	Tunisian Union of Industry, Commerce & Handicrafts	Peace Nobel Prize	Galien Forum Africa	Plenary Panel - women in stem in africa
2019	Albert Bourla	Pfizer Inc.	Chairman & Chief Executive Officer	Galien Forum USA	How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2021	Albert Bourla	Pfizer Inc.	Chairman & Chief Executive Officer	Galien Forum USA	Covid-19 vaccine development & the enduring impact on life sciences innovation – speed, collaboration, clinical trial advancement & manufacturing
2020	Abdoulaye Bousso	Senegal Emergency Health Operations Center	Director	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2013	Marc M. Boutin	National Health Council	Chief Executive Officer	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2014	Gilles Bouvenot	National Academy of Medicine	Member	Galien Foum Monaco	Innovation at what cost? make the voice of science and reason heard
2013	Robert Bradway	Amgen	Chairman & Chief Executive Officer	Galien Forum USA	Drugging the undruggable» with novel approaches to small molecule design
2021	Vincent Bretin	UNITAID International, France	Director of Results	Galien Forum Africa	« one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2013	Karin Briner	Novartis	Vice President & Head, Global Discovery Chemistry,	Galien Forum USA	Drugging the undruggable» with novel approaches to small molecule design
2020	Sabine Brookman-May	Janssen Research & Development, LLC	Executive Medical Director, Late Development, Solid Tumor	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2022	Melissa Brotz	Abbott Laboratories	Chief Marketing & Communications Officer	Galien Webinars Series	Golden Jubilee - Best MedTech Category
2018	Denis Broun	CIPLA	Head of Government Affairs,	Galien Forum Africa	Universal access to essential & others medicines
2014	Michael S. Brown	UT Southwestern Medical Center at Dallas	Nobel Laureate, Professor of Molecular Genetics & Internal Medicine	Galien Forum USA	Heart attack guidelines
2013	Michael S. Brown	UT Southwestern Medical Center at Dallas	Nobel Laureate, Professor of Molecular Genetics & Internal Medicine	Galien Forum USA	Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2013	Paula Brown	Novan, Inc. University of North Carolina, Chapel Hill, Co-Founder of Habergeon LLC	Chief Development Officer,Professor of Public Health Leadership	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2021	Jason Brubaker	Blueprint Medicines	Vice President Medicinal Chemistry	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021	Anne Bruinvels	Px HealthCare	Chief Executive Officer	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021	James Kyle Bryan	IQVIA Biotech	Chief Medical Officer	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2022	Aby Buchbinder		Global Program Head	Galien Week of Innovation	Laureates Media Presentation
2022	Ulrike K Buchwald	Merck & Co., Inc	Executive Director, Global Clinical Development, Vaccine	Galien Week of Innovation	Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2013	Samantha Budd	Neuroscience iMed at AstraZeneca R&D	Vice President	Galien Forum USA	Neurodegenerative disease drug progress
2022	Heather Bukant	Edwards Lifesciences	Director, Global Communications	Galien Webinars Series	Golden Jubilee - Best MedTech Category
2022	Koos Burggraaf	Centre for Human Drug Research (CHDR)	CEO	Galien Forum Netherlands	#VALUE!
2022	Paul Burton	Moderna	Chief Medical Officer	Galien Forum USA	Covid pandemic science 2022: current vaccines and treatments and the future outlook
2021	Amy K. Butler	Thermo Fisher Scientific	Vice President & General Manager of Cell Biology,	Galien Forum USA	The marriage of technology & medicine: bringing out the best in each other
2016	Sean Caffey	Replenish, Inc.	Co-Founder, Chairman, & Chief Executive Officer of Auricle, LLC. Co-Founder & Chairman	Galien Forum USA	Next generation antimicrobials – shaping policy to develop new business models
2015	Sean Caffey	Replenish, Inc.	Co-Founder, Chairman, & Chief Executive Officer of Auricle, LLC. Co-Founder & Chairman	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2022	Giovanni Caforio	Bristol Myers Squibb	Chairman & Chief Executive Officer	Galien Forum USA	CEO Panel
2022	Robert M. Califf	Food and drug administration	Commissioner	Galien Forum USA	Keynote
2021	Robert M Califf	Verify & Google Health; Adjunct Professor, Duke University & Stanford University; Former FDA Deputy Commissioner to President Barack Obama	Head of Clinical Policy & Strategy,	Galien Forum USA	The future is decentralized -- how the paradigm has changed & what it means for modern trials
2013	Robert M. Califf	Clinical & Translational Medicine, Director of the Duke Translational Medicine Institute (DTMI), & Professor of Medicine in the Division of Cardiology Duke University	Vice Chancellor	Galien Forum USA	The promise of gene therapy
2017	John Camm	St George’s, University of London	Professor of Clinical Cardiology	Galien Forum USA	Atrial fibrillation
2020	Monique Canto-Sperber	CNRS, France	Director of Research	Jerusalem Ethics Forum	Up-to-date reflection on society, medicine & reproduction
2019	Monique Canto-Sperber	CNRS, France	Director of Research	Jerusalem Ethics Forum	Human reproduction: technical limit, ethical limit
2022	Renaud Capdeville, MD	Novartis	Global Program Head AML	Galien Week of Innovation	Laureates Media Presentation
2012	John Castellani	Pharmaceutical Research Manufacturers of America (PhRMA)	President & Chief Executive Officer	Galien Forum USA	21st century science: building partnerships, managing for success
2021	Jeffrey P. Castelli	Amicus Therapeutics	Chief Development Officer	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2021	Cecile Cecile	Association of Burkinabe Women Lawyers	Lawyers	Galien Forum Africa	Socio-economic consequences, equity & gender in the global health security
2021	Eric Chan	Teva Pharmaceuticals	Director of Product Management in Digital Health	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2010	Paul Chew	Sanofi-Aventis US Safety Signal Detection: The Promise & the Pitfalls“	Senior Vice President,Chief Scientific Officer/Chief Medical Officer, Dr.	Galien Forum USA	The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2020	Moredreck Chibi	WHO Africa Regional Office	Innovations Program Officer	Galien Forum Africa	Youth forum: leadership & young people facing covid-19
2020	Moredreck Chibi	WHO Africa Regional Office	Innovation Program Officer	Galien Forum Africa	What place for digital health & innovations? sub-theme 3:
2019	Beatrice Childs	France	Psychoanalyst	Jerusalem Ethics Forum	Personalized genomics medicine: the value of knowing
2021	Herve Chneiweiss	CNRS	Neurolugue Director de Resercher	Galien Webinars Series	The impact of digital technology in clinical trials: ethical considerations (french edition)
2020	Mohamed Khaled Chouli	Large Social Organizations (Morocco)	Head of Department of Pre-clinical Sciences & Manager	Galien Forum Africa	Covid 19 drug supply chain in africa: challenges & perspectives
2021	Khady Cisse	Organization for the Health of Children & Women – Cote d’Ivoire	President	Galien Forum Africa	The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2021	Alessio Ciulli	University of Dundee	Professor of Chemical & Structural Biology, School of Life Sciences,	Galien Forum USA	Drugging the undruggable» with novel approaches to small molecule design
2021	Tony Clapsis	CVS Clinical Trial Services	Vice President	Galien Forum USA	The future is decentralized -- how the paradigm has changed & what it means for modern trials
2020	Helen Clark	EITI International	President	Galien Forum Africa	Impact of the covid 19 pandemic on the natural resources sector sub-theme 2:
2022	Christine Clemson	Albireo Pharma, Inc.	SVP, Global Head of Medical Affairs	Galien Week of Innovation	BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021	Ron Cohen	Acorda Therapeutics, Inc.	President & Chief Executive Officer	Jerusalem Ethics Forum	The ethical obligations of pharmaceutical companies in a global health emergency – case study: covid-19 vaccines
2021	Bruno Cohen	The Galien Foundation	Chairman	Galien Forum Africa	Youth leadership training (part 1)
2021	Bruno Cohen	The Galien Foundation	Chairman	Galien Forum Africa	Youth leadership training
2021	Bruno Cohen	The Galien Foundation	Chairman	Galien Forum Africa	Inaugural Panel
2021	Bruno Cohen	The Galien Foundation	Chairman	Galien Forum Africa	Closing ceremony
2020	Brigitte Fanny Cohen	Media	Journalist	Jerusalem Ethics Forum	Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2010	Ron Cohen	Acorda Therapeutics	President & Chief Executive Officer	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2022	Ron Cohen	Acorda	President & CEO - Moderator	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2022	Heidi Cole	GT Medical Technologies, Inc.	Ass VP, R&D GT Medical Technologies	Galien Week of Innovation	Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2021	Awa Marie Coll Seck	CN-ITIE	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Youth leadership training (part 1)
2021	Awa Marie Coll Seck	CN-ITIE	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Youth leadership training
2021	Awa Marie Coll Seck	Minister of State (Senegal)	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Women & stem in the global health security context
2021	Awa Marie Coll Seck	President of NC-EITI, President of the Scientific Committee	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2021	Awa Marie Coll Seck	President of NC-EITI, President of the Scientific Committee	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Inaugural Panel
2021	Awa Marie Coll Seck	NC-EITI,	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Closing ceremony
2018	Awa Marie Coll Seck	CN-ITIE	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Which plan for non communicable diseases?
2018	Awa Marie Coll Seck	CN-ITIE	Minister of State, President of the CN-ITIE, President of the Scientific Committee	Galien Forum Africa	Remarkable women engage for humanity
2022	Steven Collens	MATTER	CEO	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2020	Beth-Ann Coller	Merck & Co., Inc	Executive Director, Global Clinical Development	Galien Week of innovation	Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2014	Rory Collins	the University of Oxford's Clinical Trials Unit	Co-Director	Galien Forum USA	Heart attack guidelines
2018	Bernard Colombo	Roche Diagnostics France	Chairman	Galien Forum Africa	Which plan for non communicable diseases?
2012	Meryl Comer	Geoffrey Beene Foundation Alzheimer's Initiative	President	Galien Forum USA	Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2021	Celestin Compaore	DMPA-SC Project, Jhpiego 6 International	Regional Director	Galien Forum Africa	The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2020	Brian S. Conklin	Edwards Lifesciences	Senior Distinguished Engineer	Galien Week of innovation	How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2021	Vlad Coric	Biohaven Pharmaceuticals	Chief Executive Officer	Galien Week of innovation	What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2022	Mark Cornfeld	Incyte Corp.	VP Hemato. Onco. Clinical Det	Galien Week of Innovation	Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2020	Toumani Corrah	African Research Excellence Fund (AREF) (London - Gambia- USA)	Executive Director	Galien Forum Africa	Research facing covid 19
2018	Tumani Corrah	AREF, Gambie	Chief Executive Officer	Galien Forum Africa	Financing africa’s healthcare
2022	Christopher Corsico	GSK	Global Head of Development	Galien Forum UK	Clinical trials & regulations: what have we learned from covid?
2020	Sophie Coulbary	Association of Women Doctors of Senegal AFEMS (Senegal)	President	Galien Forum Africa	Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2022	Joseph Coulloc'h	AAZ-LMb	Founder & President	Galien Webinars Series	Golden Jubilee - Best MedTech Category
2022	Angela Coxon,	Amgen	VP Research	Galien Week of Innovation	Laureates Media Presentation
2012	Craig Crews		John C. Malone Professor of Molecular, Cellular, & Developmental Biology, Yale University	Galien Forum USA	Drugging the undruggable» with novel approaches to small molecule design
2020	Dan Cua	Janssen Biotech, Inc.	Vice President IL-23 Pathway Area Leader for the Immunology Therapeutic Area	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2022	Tom Daniel	Scripps Research Institute	MD Board of Directors	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2011	Stephen Daniels	Hospital Colorado	Pediatrician-in-Chief, University of Colorado School of Medicine, L Joseph, Butterfield Chair in Pediatrics	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2012	Alice Dautry	Institut Pasteur	President	Galien Forum USA	Infectious diseases: a global healthcare challenge
2019	Benjamin David	Pouah Center Israel	Medical Ethics Doctor	Jerusalem Ethics Forum	Personalized genomics medicine: the value of knowing
2019	Benjamin David	Pouah Center Israel	Medical Ethics Doctor	Jerusalem Ethics Forum	Ethical considerations around patient choice & human enhancement in healthcare?
2011	Brett Davis	Oracle Corporation,	Senior Director, Personalized Healthcare, Health Sciences Global Business Unit	Galien Forum USA	The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2022	Rob Davis	Merck & co.	CEO & president,	Galien Forum USA	CEO Panel
2015	Geraldine Dawson	Duke Center for Autism & Brain Development, Duke University School of Medicine	Professor, Department of Psychiatry & Behavioral Sciences & Director,	Galien Forum USA	Autism - the next decade
2021	Steph De Bono	Eli Lilly & Company	Senior Medical Director	Galien Week of innovation	What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2012	Neil De Crescenzo	Oracle Health Sciences	Senior Vice President & General Manager,	Galien Forum USA	Welcome Remarks
2022	Adam De la Zerda	Visby Medical, Inc.	Founder and CEO	Galien Week of Innovation	Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2021	Rui De Passos Sousa	Sanofi	Global Medical Head for the TTP program	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2020	Darryl De Vivo	Columbia University Medical Center	Sidney Carter Professor of Neurology & Pediatrics,	Galien Forum USA	Spinal muscular atrophy: charting the pathway to clinical progress
2014	Laurent Degos	University of Paris Diderot & National Academy of Medicine	Member	Galien Foum Monaco	Innovation at what cost? make the voice of science and reason heard
2014	Karl Deisseroth	Stanford University	Chen Professor of Bioengineering & of Psychiatry & Behavioral Sciences,	Galien Forum USA	The brain initiative
2020	Bernard Delaey	Sanofi	Regulatory Therapeutic Area Lead	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2018	George D. Demetri	Dana-Farber Cancer Institute Ludwig Center, Harvard Medical School; Associate Director for Clinical Sciences, Dana	Senior Vice President for Experimental Therapeutics, Professor of Medicine & Director	Galien Forum USA	Cancer in a time of disruption
2022	Bela Denes	Lantheus	VP Global Medical Affairs	Galien Week of Innovation	Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2011	Alex Depaoli	NGM Biopharmaceuticals	Vice President of Translational Research,	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2015	Nancy-Ann Deparle	Consonance Capital Partners	Partner	Galien Forum USA	Us health reform: partnering, pricing & politics
2021	Sue Desmond-Hellmann	Bill & Melinda Gates Foundation	Prix Galien Committee Chair & Former Chief Executive Officer	Galien Forum USA	Vaccines, drugs & the future of pandemics - - lessons from covid-19
2020	Sue Desmond-Hellmann	Bill & Melinda Gates Foundation	Prix Galien Committee Chair & Former Chief Executive Officer	Galien Forum USA	The next 50 years of innovation: where will it come from & how do we secure it?
2020	Sue Desmond-Hellmann	Bill & Melinda Gates Foundation	Prix Galien Committee Chair & Former Chief Executive Officer	Galien Forum Africa	Research funding: state of play & perspectives sub-theme 4:
2020	Sue Desmond-Hellmann	Bill & Melinda Gates Foundation	Prix Galien Committee Chair & Former Chief Executive Officer	Galien Forum Africa	Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2020	Sue Desmond-Hellmann	Bill & Melinda Gates Foundation	Prix Galien Committee Chair & Former Chief Executive Officer	Galien Forum USA	Closing remarks
2018	Sue Desmond-Hellmann	Bill & Melinda Gates Foundation	Prix Galien Committee Chair & Former Chief Executive Officer	Galien Forum Africa	Remarkable women engage for humanity
2021	Deepika Devadas	Grand Challenges Canada	Senior Program Advisor	Galien Forum Africa	Meeting of young innovators with investors
2022	Nina Devlin	Vertex	SVP & Chief Communciations Officer	Galien Webinars Series	Golden Jubilee - Best Orphan Rare Category
2020	Djiby Diagne	Emerging Senegal Plan (BOS - PSE) (Senegal)	Operational Monitoring Office	Galien Forum Africa	Place of local production in the pharmaceutical sector sub-theme 4:
2021	Djiby Diakhate	National Council for Audiovisual Regulation CNRA – Senegal	Sociologist teacher	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2021	Adja Diakhou Ndiaye	High Council on Health Security, One Health – Senegal	Permanent Secretary	Galien Forum Africa	Women’s leadership in global health security
2021	Ndeye Fatou Diallo	Neighborhood godmother (Senegal),	Neighborhood godmother	Galien Forum Africa	Women’s leadership in global health security
2021	Mohamadou Diallo	CIO Mag	Founder & Editor in Chief	Galien Forum Africa	Women & stem in the global health security context
2021	Abdourahmane Diallo	Roll Back Malaria International – Guinea	Director	Galien Forum Africa	« one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2018	Abdourahmane Diallo	Presidency of the Republic of Guinea, Minister Counselor in charge of Health Issues	Director, Minister Counselor	Galien Forum Africa	Universal access to essential & others medicines
2017	Marc Diamond	Center for Alzheimer’s & Neurodegenerative Disease, the University of Texas, Southwestern Medical Center	Distinguished Chair in Basic Brain Injury & Repair & Director,	Galien Forum USA	Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020	Oley Dibba Wadda	GAM African Leadership Institute (Gambia)	President	Galien Forum Africa	Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2013	Andrew Dillon	National Institute for Health & Care Excellence (NICE),	Chief Executive	Galien Forum USA	Making medicines affordable
2021	Ibrahima Cheikh Diong	United NationsDirector General of ARC – International – Senegal	Assistant Secretary-General	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2021	Amadou Gallo Diop	Research & Innovation – MESRI Platform	Director General	Galien Forum Africa	Innovations & ethic for global health security
2020	Amadou Gallo Diop	Research Ministry of Higher Education, Research & Innovation (Senegal)	Director General	Galien Forum Africa	Research funding: state of play & perspectives sub-theme 4:
2021	Waly Diouf	DANGOTE Cement Senegal	Director of Human Resources	Galien Forum Africa	Meeting of young innovators with investors
2021	Abdoulaye Diouf Sarr	Minister of Health & Social Action Senegal	Minister of Health	Galien Forum Africa	« one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2018	Abdoulaye Diouf Sarr	Senegal	Minister of Health	Galien Forum Africa	Financing africa’s healthcare
2022	Graham Dixon	Mayne Pharma	Chief Scientific Officer	Galien Week of Innovation	Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2021	Yacine Djibo	Speak Up Africa	Founder & Executive Director	Galien Forum Africa	Women & stem in the global health security context
2020	Yacine Djibo	Speak Up Africa	Founder & Executive Director	Galien Forum Africa	Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4:
2022	Mikael Dolsten	Pfizer Inc	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA - Chair	Covid pandemic science 2022: current vaccines and treatments and the future outlook
2021	Mikael Dolsten	Pfizer Inc	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	Where will new therapies & vaccines come from?
2020	Mikael Dolsten	Pfizer Inc	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	The promise of gene therapy
2020	Mikael Dolsten	Pfizer Inc	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2020	Mikael Dolsten	Pfizer Inc	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	Drugging the undruggable» with novel approaches to small molecule design
2017	Mikael Dolsten	Pfizer Inc.	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2016	Mikael Dolsten	Pfizer Inc.	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	Precision medicine: delivering on the promise
2014	Mikael Dolsten	Pfizer Inc.	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	A new agenda for global health
2013	Mikael Dolsten	Pfizer Inc	Chief Scientific Officer & President, Worldwide Research	Galien Forum USA	Improving efficiency in drug development
2021	Habib Douagui	Algerian Society of Asthmology, Allergology & Clinical Immunology (SAAIC); Member of the Executive Committee of Respiratory Diseases & Allergies at the World Allergy Organization (WAO) International – Algeria	President	Galien Forum Africa	« one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2020	Philippe Douste-Blazy	United Nations	Deputy General Secretary	Jerusalem Ethics Forum	Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2019	Philippe Douste-Blazy	United Nations	Deputy General Secretary	Jerusalem Ethics Forum	Health policy & financing innovation: ethical considerations, cost & the role of the patient
2019	Philippe Douste-Blazy	United Nations	Deputy General Secretary	Jerusalem Ethics Forum	2020/2030 agenda “facing the next ethical challenges”
2018	Philippe Douste-Blazy	United Nations	Deputy General Secretary	Galien Forum Africa	Which health insurance for the african continent?
2018	Philippe Douste-Blazy	United Nations	Deputy General Secretary	Galien Forum Africa	Which health insurance for the african continent?
2022	Cristal Downing	Merck & Co	Executive Vice President & Chief Communications and Public Affairs Officer	Galien Webinars Series	Golden Jubilee - Best Pharmaceutical Category
2015	William F. Doyle	NovoCure, Ltd.	Executive Chairman	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2019	Nancy Dreyer	IQVIA	Chief Scientific Officer	Galien Forum USA	Digital health -orchestrating patient- centricity from molecule to market
2016	Daniel J. Drucker	Research Institute Mt. Sinai Hospital Toronto Ontario, Canada	Senior Scientist, Lunenfeld Tanenbaum	Galien Forum USA	Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2020	Philippe Duneton	United Nations	Executive Director	Galien Forum Africa	Place of local production in the pharmaceutical sector sub-theme 4:
2018	Philippe Duneton	UNITAID	Director	Galien Forum Africa	Universal access to essential & others medicines
2022	Adam Dunki-Jacobs	Standard Bariatrics, Inc.	Titan SGS®	Galien Week of Innovation	Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2021	Cristina Duran	AstraZeneca	Chief Digital Health Officer, R&D	Galien Forum USA	The future is decentralized -- how the paradigm has changed & what it means for modern trials
2022	Tim Durst	Accenture	Global Medical Technology Sector Lead - Moderator	Galien Week of Innovation	Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2014	Gerard Duru	CNRS	Honorary Research Director	Galien Foum Monaco	Innovation at what cost? make the voice of science and reason heard
2021	Mette Dyhrberg	Mymee	Founder & Chief Executive Officer	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Craig Eagle	Guardant Health	CMO	Galien Week of Innovation	Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2021	Jamey Edwards	Cloudbreak Health	Chief Executive Officer	Galien Webinars Series	Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020	Mark Milton Edwards	Teva Pharmaceutical Industries	Head of Product & Health Solutions – Digital Health	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2020	Pierre Effa	Pan-African Ethics & Bioethics Congress (COPAB)	President	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2020	Serge Eholie	Ivory Coast	Head of the ALERRT work platform	Galien Forum Africa	Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3:
2010	Paul Eisenberg	Amgen Strategies for Incorporating Continuous Benefit: Risk into Drug Developmen	Global Regulatory Affairs & Safety	Galien Forum USA	The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2022	Sathya Elumalai	Aidar Health	President & CEO Aidar Health	Galien Week of Innovation	Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2021	Ezekiel J. Emanuel	University of Pennsylvania	Vice Provost for Global Initiatives & Professor & Co-Director, Healthcare Transformation Institute	Jerusalem Ethics Forum	The ethical obligations of pharmaceutical companies in a global health emergency – case study: covid-19 vaccines
2014	Ezekiel J. Emanuel	University Professor Perelman School of Medicine & The Wharton School University of Pennsylvania	Vice Provost for Global Initiatives, Chair, Department of Medical Ethics & Health Policy Levy	Galien Forum USA	Us health reform
2019	David R. Epstein	Flagship Pioneering	Executive Partner	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2017	David Epstein	Novartis Pharmaceuticals	Former Chief Executive Officer & Division Head	Galien Forum USA	Moderator
2016	David Epstein	Novartis Pharmaceuticals	Former Chief Executive Officer & Division Head	Galien Forum USA	Promise - & politics - in the fight against cancer
2016	David Epstein	Novartis Pharmaceuticals	Former Chief Executive Officer & Division Head	Galien Forum USA	Promise - & politics - in the fight against cancer
2011	Robert S. Epstein	Medco Health Solutions, Inc.	Chief Clinical Research & Development Officer	Galien Forum USA	What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021	Barış Erdoğan	Clinerion	Chief Executive Officer	Galien Week of innovation	Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2020	Daniel Everitt	TB Alliance	Vice President & Chief Medical Officer	Galien Week of innovation	Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2021	Ibrahima Soce Fall	Emergency Response at WHO International – Senegal	Assistant Director-General	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 6
2020	Ibrahima Soce Fall	Emergency Response (WHO-Geneva)	Assistant Director-General	Galien Forum Africa	Health break
2021	Barbara Fant	Clinical Research Consultants, Inc.	President	Galien Week of innovation	What is med tech innovation doing for patients with specialized needs for treatment?
2020	Barbara Fant	Clinical Research Consultants, Inc.	President	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2021	Anthony S. Fauci	NIAID & Chief Advisor to the President of the United States	Director	Galien Forum USA	Keynote
2021	Anthony S. Fauci	NIAID & Chief Advisor to the President of the United States	Director	Galien Forum USA	Galien golden jubilee special address
2022	Anthony S. Fauci	NIAID & chief advisor to the president of the united states	Director	Galien Forum USA	Special Address Galien Golden Jubilee
2021	Olufunmilayo Fawole	Faculty of Public Health at the University of Ibadan – Nigeria	Epidemiologist & Dean	Galien Forum Africa	Involvement of women researchers in the mhw
2021	Jessica Federer	Bayer	Partner Boston Millenia Partners Former CDO	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2021	Jessica Federer	Bayer	Partner Boston Millenia Partners Former CDO	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 3
2021	Jessica Federer	Bayer	Partner Boston Millenia Partners Former CDO	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19
2021	Jessica Federer	Bayer, HUMA	Managing Director; HUMA Former Chief Digital Officer	Galien Webinars Series	Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020	Jessica Federer	Bayer	Partner Boston Millenia Partners Former CDO	Galien Webinars Series	Digital health improving research & care
2022	Jessica Federer	Supernode Ventures	MP - Moderator	Galien Week of Innovation	Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2022	Jessica Federer	Supernode Ventures	MP - Moderator	Galien Week of Innovation	Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2014	Mark Feinberg	IAVI	Chief Executive Officer	Galien Forum USA	Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2020	Marc Fellous	Bayer	Global Medical Affairs Head	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2016	David Feltquate	Bristol-Myers Squibb	Vice President, Immuno-Oncology Development,	Galien Forum USA	Precision medicine: delivering on the promise
2014	Adolfo Ferrando	Institute for Cancer Genetics,Columbia University Medical Center	Prize Winner & Associate Professor of Pediatrics & Pathology,	Galien Forum USA	Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2019	Mauro Ferrari	Houston Methodist Research Institute,Houston Methodist Hospital System	Ernest Cockrell Jr. Presidential Distinguished Chair, President & Chief Executive Officer, Executive Vice President,	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2019	Michael Fischbach	Stanford University	Associate Professor of Bioengineering	Galien Forum USA	The gut microbiome: opportunities & challenges
2021	Senait Fisseha	Susan Thompson Buffett Foundation International – Ethiopia	Director of International Programs	Galien Forum Africa	Socio-economic consequences, equity & gender in the global health security
2021	Senait Fisseha	Susan Thompson Buffett Foundation International – Ethiopia	Director of International Programs	Galien Forum Africa	Closing ceremony
2020	Senait Fisseha	Susan Thompson Buffett Foundation International – Ethiopia	Director of International Programs	Galien Forum Africa	Place of women in innovation related to covid 19 sub-theme 2:
2011	Martin Fitchet	Johnson & Johnson, Pharmaceutical Research & Development	Chief Operating Officer	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2018	Julian Fleet	START-International (USA)	Ethical specialist	Galien Forum Africa	The health consequences of climate change
2019	Emmanuel Fombu	The Future of Healthcare	Medical Futurist	Galien Forum USA	Digital health -orchestrating patient- centricity from molecule to market
2019	Emmanuel Fombu	The Future of Healthcare	Medical Futurist	Jerusalem Ethics Forum	“artificial intelligence & ethics”
2021	Joanne Micale Foody	Esperion	Chief Medical Officer	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2017	Jean Francois Formela	Atlas Ventures	Partner	Galien Forum USA	Addressing unmet medical needs with early-stage life science venture capital
2014	Richard N. Foster	Healthcare Innovation, Yale University;Director Emeritus, McKinsey & Company	Venture Partner, Lux Capital; Special Advisor to the President	Galien Forum USA	The future of digital health
2021	Jacqualyn Fouse	Agios	Chief Executive Officer	Galien Forum USA	How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2020	Susannah Fox	U.S. Department of Health & Human Services	Independent Consultant & Health Care Innovation Leader & Former Chief Technology Officer	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2021	Kenneth C. Frazier	Merck & Co., Inc	Chairman of the Board - President & Chief Executive Officer	Galien Forum USA	Keynote remarks & a discussion with
2020	Kenneth C. Frazier	Merck & Co., Inc	Chairman of the Board - President & Chief Executive Officer	Galien Forum USA	Combating the opioid crisis in america
2015	Bud Frazier	Baylor College of Medicine & the University of Texas Health Science Center, Chief of the Center for Cardiac Support at The Texas Heart Institute	Professor of Surgery	Galien Forum USA	Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2015	Kenneth C. Frazier	Merck & Co., Inc	Chairman of the Board - President & Chief Executive Officer	Galien Forum USA	Us health reform: partnering, pricing & politics
2013	Kenneth C. Frazier	Merck & Co., Inc	Chairman of the Board - President & Chief Executive Officer	Galien Forum USA	Affordable care act us healthcare in transition: the stakes for industry
2016	Maria C. Freire	Foundation for the National Institutes of Health	President & Executive Director	Galien Forum USA	Next generation antimicrobials – shaping policy to develop new business models
2012	Maria C. Freire	Albert & Mary Lasker Foundation	President	Galien Forum USA	Infectious diseases: a global healthcare challenge
2022	Greg Friberg	Amgen Inc.	VP Medical Affairs ELMAC Region	Galien Week of Innovation	Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2011	Jeffrey Friedman	Investigator Howard Hughes Medical Institute, Laboratory of Genetics, The Rockefeller University	Marilyn M Simpson Professor	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2022	Johannes Fruehauf	BioLabs	Founder, President	Galien Week of Innovation	Laureates Media Presentation
2022	Johannes Fruehauf	BioLabs and LabCentral	Founder President	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020	Rene Frydman	Antoine Beclere Hospital, France	Head of the Department of Gynecology & Obstetrics	Jerusalem Ethics Forum	Up-to-date reflection on society, medicine & reproduction
2020	Rene Frydman	Antoine Beclere Hospital, France	Head of the Department of Gynecology & Obstetrics	Jerusalem Ethics Forum	Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2019	Rene Frydman	Antoine Beclere Hospital, France	Head of the Department of Gynecology & Obstetrics	Jerusalem Ethics Forum	Human reproduction: technical limit, ethical limit
2019	Rene Frydman	Antoine Beclere Hospital, France	Head of the Department of Gynecology & Obstetrics	Jerusalem Ethics Forum	2020/2030 agenda “facing the next ethical challenges”
2012	Les Funtleyder	Polliwog	Fund Manager	Galien Forum USA	The changing face of chinese healthcare
2011	Les Funtleyder	Miller Tabak	Healthcare Strategist & Portfolio Manager, Health Care Transformation Fund	Galien Forum USA	Funding innovation new trends in the healthcare m&a l& scape
2012	John Furey	Spark Therapeutics Inc.	Chief Operating Officer	Galien Forum USA	Making medicines affordable
2019	Gilles Gade	Cross River	Founder, President & Chief Executive Officer	Jerusalem Ethics Forum	Health policy & financing innovation: ethical considerations, cost & the role of the patient
2019	Gilles Gade	Cross River	Founder, President & Chief Executive Officer	Jerusalem Ethics Forum	2020/2030 agenda “facing the next ethical challenges”
2018	Priya Gajraj	PNUD - Dakar	Resident Representative	Galien Forum Africa	Which health insurance for the african continent?
2012	Diana Gallagher	Biogen	Head of External Innovation,	Galien Forum USA	Infectious diseases: a global healthcare challenge
2021	Pushkal Garg	Alnylam	Chief Medical Officer	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2020	Pushkal Garg	Alnylam	Chief Medical Officer	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2021	Diane Gashumba	Former Minister of Health of Rwanda	Ambassador	Galien Forum Africa	Women’s leadership in global health security
2020	Diane Gashumba	Former Minister of Health of Rwanda	Ambassador	Galien Forum Africa	Health & socio-economic impact of the covid 19 pandemic in africa sub-theme 1: resilience of health systems & continuity of care: state of play, challenges & rerspectives
2018	Diane Gashumba	Former Minister of Health of Rwanda	Ambassador	Galien Forum Africa	Which health insurance for the african continent?
2022	Natacha Gassenbach	Biogen	Head of Corporate Affairs, Chief Communications Officer	Galien Webinars Series	Golden Jubilee - Best Orphan Rare Category
2022	Judy Gawlik Brown	Amgen	SVP, Corporate Affairs	Galien Webinars Series	Golden Jubilee - Best Orphan Rare Category
2021	Julie Louise Gerberding	Merck & Co., Inc.	Chief Patient Officer & Executive Vice President, Population Health & Sustainability	Jerusalem Ethics Forum	Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2016	Julie Louise Gerberding	Merck & Co., Inc.	Executive Vice-President, Chief Patient Officer & Head of Policy	Galien Forum USA	Keynote
2015	Julie Louise Gerberding	Merck & Co., Inc.	Executive Vice-President, Chief Patient Officer & Head of Policy	Galien Forum USA	Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2012	Julie Louise Gerberding	Merck Vaccines, Merck & Co., Inc.; Former Director, Centers for Disease Control & Prevention (CDC)	President	Galien Forum USA	Infectious diseases: a global healthcare challenge
2011	Barry Gertz	Merck	Senior Vice President, & head of clinical research & regulatory affairs	Galien Forum USA	What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021	Ken Getz	Tufts Center for the Study of Drug DevelopmentTufts University School of Medicine	Director	Jerusalem Ethics Forum	Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2021	Tedros A. Ghebreyesus	WHO	Director General	Galien Forum Africa	Inaugural Panel
2021	Tedros A. Ghebreyesus	WHO	Director General	Galien Forum Africa	Closing ceremony
2018	Tedros A. Ghebreyesus	WHO (World Health Organization)	Director General	Galien Forum Africa	Which health insurance for the african continent?
2018	Tedros A. Ghebreyesus	World Health Organization	Director General	Galien Forum Africa	Which health insurance for the african continent?
2020	Gargee Ghosh	Bill & Melinda Gates Foundation	Director of Development Policy & Finance	Galien Forum Africa	Financing the response to covid 19
2018	Gambie Gargee Ghosh	Bill & Melinda Gates Foundation	Director of Development Policy & Finance	Galien Forum Africa	Financing africa’s healthcare
2022	Mati Gill	AION Labs	CEO	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2014	Michael Giordano	Oncology & Immunoscience at Bristol-Myers Squibb	Senior Vice President, Head of Development,	Galien Forum USA	Cancer immunotherapeutics
2020	Nicanor Giorgio Austriaco	Providence College	Biology & Theology	Jerusalem Ethics Forum	Societal, legal & ethical challenges around access to covid-19 vaccines
2019	Nicanor Giorgio Austriaco	Providence College	Biology & Theology	Jerusalem Ethics Forum	Ethical considerations around patient choice & human enhancement in healthcare?
2020	Sophie Gladima	Senegal	Minister of Petroleum & Energy	Galien Forum Africa	Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2018	Sophie Gladima Siby	Senegal	Minister of Industries	Galien Forum Africa	Plenary Panel - women in stem in africa
2021	Laurie H. Glimcher	Harvard Medical School	President & Chief Executive Officer, Dana-Farber Cancer Institute, Richard & Susan Smith, Professor of Medicine,	Galien Forum USA	New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2015	Laurie H. Glimcher	Cornell University, New York	Dean of Weill Cornell Medical College & Provost for Medical Affairs	Galien Forum USA	Microbiota in human diseases
2014	Laurie H. Glimcher	Cornell University	Dean of Weill Cornell Medical College & Provost for Medical Affairs	Galien Forum USA	Cancer immunotherapeutics
2021	Claire Gloeckner	Becton-Dickinson	Senior Staff Scientist	Galien Week of innovation	What is med tech innovation doing for patients with specialized needs for treatment?
2014	Joseph Goldstein	UT, Southwestern Medical Center at Dallas	Nobel Laureate, Professor of Molecular Genetics & Internal Medicine,	Galien Forum USA	Heart attack guidelines
2013	Joseph Goldstein	UT, Southwestern Medical Center at Dallas	Nobel Laureate, Professor of Molecular Genetics & Internal Medicine,	Galien Forum USA	Personalized medicine: effect on drug r&d & patient care
2015	Jeff Gordon	Robert Glaser University Center for Genome Sciences & Systems Biology at Washington University in St. Louis	Professor & Director	Galien Forum USA	Microbiota in human diseases
2015	Jeff Gordon	Robert Glaser University Center for Genome Sciences & Systems Biology at Washington University in St. Louis	Professor & Director	Galien Forum USA	Keynote
2016	Alex Gorsky	Johnson & Johnson	Chairman of the Board - President & Chief Executive Officer	Galien Forum USA	Promise - & politics - in the fight against cancer
2013	Alex Gorsky	Johnson & Johnson	Chairman of the Board - President & Chief Executive Officer	Galien Forum USA	Affordable care act us healthcare in transition: the stakes for industry
2016	Scott Gottlieb	Food & Drug Administration	Former Commissioner of the U.S.	Galien Forum USA	Keynote dialogue life science companies: public health institutions or black hats?
2021	Raymonde Goudou Coffie	Lakes District Former Minister of Health Ivory Coast	Minister Governor	Galien Forum Africa	Women’s leadership in global health security
2020	Raymonde Goudou Coffie	Lakes District Former Minister of Health Ivory Coast	Minister Governor	Galien Forum Africa	Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2021	Ann M. Graybiel	MIT	Institute Professor, Department of Brain & Cognitive Science,	Galien Forum USA	Future pathways in translational medicine -- academic-industry collaborations in cns diseases
2010	Paul Greengard	Rockefeller University	Nobel Laureate Professor	Galien Forum USA	Translational neuroscience: academic-industrial collaborations in cns diseases
2016	Philip D. Gregory	Bluebird	Chief Scientific Officer	Galien Forum USA	The promise of gene therapy
2020	Jessica Grossman	Medicines360	Chief Executive Officer	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2014	Dan Grossman	Boston Consulting Group	Managing Director & Senior Partner. Health Care Practice Area,	Galien Forum USA	A new agenda for global health
2014	Scott Grundy	Texas Southwestern Medical Center; Center for Human Nutrition University	Professor	Galien Forum USA	Heart attack guidelines
2021	Henri Gueye	EYONEInvestors	Founder & Chief Executive Officer	Galien Forum Africa	Meeting of young innovators with investors
2021	Arame Gueye Sene	Social Change Factory – Senegal	Executive Director	Galien Forum Africa	The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2022	Vishal Gulati	Deeptech / Healthtech VC	Director	Galien Forum UK	Digital health innovation: a key driver of next generation healthcare – what & when?
2021	Ira Gupta	GSK	Vice President, Medicines Development Leader – Global Oncology Therapy Area	Galien Week of innovation	Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2020	Fred Guterl	The Fate of the Species	Author	Jerusalem Ethics Forum	Tracking bioethics: transparency, trust & the industry’s social imperatives
2021	Sebastian Guth	Bayer Pharmaceuticals, Americas Region	President	Galien Forum USA	The future is decentralized -- how the paradigm has changed & what it means for modern trials
2020	Shwen Gwee	Bristol Myers Squibb	Vice President & Head of Global Digital Strategy	Galien Webinars Series	Digital health in the aftermath of covid-19
2012	Kimberly Ha	Biopharm Insight	Global Editor	Galien Forum USA	The changing face of chinese healthcare
2011	Kimberly Ha	Biopharm Insight	Global Editor	Galien Forum USA	Funding innovation new trends in the healthcare m&a l& scape
2021	Amir Aman Hagos	Health of Ethiopia International – Ethiopia	GFF Strategic Advisor	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 1
2022	William N. Hait	Johnson & Johnson	Global Head, Research & Development	Galien Forum USA	Diversity and health equity in the future creation of medicine
2014	William N. Hait	Janssen Research & Development	Global Head, Research & Development	Galien Forum USA	A new agenda for global health
2015	John Hambor	Research Administration Boehringer Ingelheim Pharmaceuticals, Inc.	Distinguished Research Fellow	Galien Forum USA	Microbiota in human diseases
2016	Margaret A. Hamburg	Food & Drug Administration	Former Commissioner of the U.S.	Galien Forum USA	Promise - & politics - in the fight against cancer
2015	Margaret A. Hamburg	Food & Drug Administration	Former U.S. Commissioner	Galien Forum USA	Delivering on the patient promise of gene therapy
2012	Margaret A. Hamburg	U.S. Food & Drug Administration	Commissioner,	Galien Forum USA	Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2012	Margaret A. Hamburg	Food & Drug Administration	Commissioner	Galien Forum USA	Infectious diseases: a global healthcare challenge
2018	Patrice A. Harris	American Medical Association	President-elect,	Galien Forum USA	Novel approaches to combatting opioid addiction
2021	Fatima Hassan	Health Justice Initiative HJI – South Africa	Founder	Galien Forum Africa	Innovations & ethic for global health security
2012	Fred Hassan	Bausch & Lomb	Chairman of the Board - President & Chief Executive Officer	Galien Forum USA	“looking back, moving forward”
2020	Richard Hatchett	Coalition for Epidemic Preparedness Innovations	Chief Executive Officer	Galien Forum Africa	Vaccine production: state of play & perspectives sub-theme 3
2020	Richard Hatchett	Coalition for Epidemic Preparedness Innovations	Chief Executive Officer	Jerusalem Ethics Forum	Societal, legal & ethical challenges around access to covid-19 vaccines
2019	Richard Hatchett	Coalition for Epidemic Preparedness Innovations	Chief Executive Officer	Galien Forum USA	Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2018	Richard Hatchett	Coalition for Epidemic Preparedness Innovations	Chief Executive Officer	Galien Forum Africa	Universal access to essential & others medicines
2022	Richard M. Haupt	Merck	Vice President	Galien Week of Innovation	Laureates Media Presentation
2020	David Hayes	Biotronik	Chief Medical Officer	Galien Week of innovation	How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2020	Penny M. Heaton	Bill & Melinda Gates Gates Medical Research Institute	Chief Executive Officer	Galien Forum USA	The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2018	Michael Heffernan	Collegium Pharmaceutical	Chairman	Galien Forum USA	Novel approaches to combatting opioid addiction
2016	Michael Heffernan	Collegium Pharmaceutical	Chairman	Galien Forum USA	Next generation antimicrobials – shaping policy to develop new business models
2010	Thomas Heffner	Pfizer	Executive Director of Worldwide Business Development ,	Galien Forum USA	Translational neuroscience: academic-industrial collaborations in cns diseases
2022	Kristen Hege	Bristol Myers Squibb	SVP Onco/Hemato /Cell Therapy	Galien Week of Innovation	Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2022	Nicky Hekster	The Netherlands	Independent freelance teacher	Galien Forum Netherlands	#VALUE!
2021	Marie-Pierre Hellio Le Graverand	Pfizer	Senior Vice President, Head of Clinical Development & Operations	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-20
2021	Marie-Pierre Hellio Le Graverand	Pfizer	Senior Vice President, Head of Clinical Development & Operations	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 4
2011	Hunt Henrie	Ferghana Partners	Managing Director a specialist investment banking group	Galien Forum USA	Funding innovation new trends in the healthcare m&a l& scape
2012	Karl Hick	Takeda	Chief Digital & Information Officer	Galien Forum USA	The promise of gene therapy
2013	Kathy A. High	Spark Therapeutics	President & Head of Research & Development	Galien Forum USA	Fireside chat \| delivering on the patient promise of gene therapy
2012	Kathy High	Spark Therapeutics	President & Head of Research & Development	Galien Forum USA	The promise of gene therapy
2021	Samit Hirawat	Bristol Myers Squibb	Executive Vice President, Chief Medical Officer, Global Drug Development	Galien Forum USA	New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2012	R.T. (Terry) Hisey	Deloitte LLP	Vice Chairman & US Life Sciences Leader	Galien Forum USA	The changing face of chinese healthcare
2021	Colin Hislop	Eiger Biopharmaceuticals Inc.	Senior Vice President of Clinical & Development Operations	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2022	Colin Hislop	Eiger BioPharmaceuticals, Inc.	Sr VP Clinical&Devt Operations	Galien Week of Innovation	Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2022	John Hoekman	Impel Pharmaceuticals Inc.	Chf Technology & Devt Officer	Galien Week of Innovation	Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2021	Michelle Hoiseth	Parexel International	Chief Data Officer & Corporate Vice President Medical & Scientific Services	Galien Webinars Series	Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020	Michelle Hoiseth	Parexel International	Chief Data Officer & Corporate Vice President Medical & Scientific Services	Galien Webinars Series	Digital health improving research & care
2022	Alison Holland	Medable	Head of Decentralized Clinical Trials	Galien Forum UK	Clinical trials & regulations: what have we learned from covid?
2022	Ali Holland	Medable	Head of Decentralised Clinical Trials - Moderator	Galien Week of Innovation	Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2013	David Holtzman	Disease Research Center, Washington University	Andrew B. & Gretchen P. Jones Professor & Chairman, Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer‘s	Galien Forum USA	Neurodegenerative disease drug progress
2010	Peter Honig	Astra Zeneca The New Postmarketing Pharmacovigilance Toolbox	Head,Global Regulatory Affairs,	Galien Forum USA	The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2022	Andrew Hopkins,	Exscientia	CEO	Galien Week of Innovation	Laureates Media Presentation
2013	Herve Hoppenot	Novartis Oncology, Novartis Pharmaceuticals Corporation	President	Galien Forum USA	Oncology: newer therapies
2020	Amadou Hott	Planning & International Cooperation of Senegal	Minister of Economy, Planning & Cooperation	Galien Forum Africa	Socio-economic impact of the covid 19 pandemic sub-theme 4
2021	Amadou Hott	Planning & International Cooperation of Senegal	Minister of Economy	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2016	John G. Houston	Arvinas	President & Chief Executive Officer	Galien Forum USA	Promise - & politics - in the fight against cancer
2022	Mary Howard	Design Technologies LLC	Program Director	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2016	Scott Howell	Novartis Pharmaceuticals Inc.	Vice-President & Head, US Market Access,	Galien Forum USA	Making medicines affordable
2021	Dennis E. Hruby	SIGA Technologies, Inc.	Chief Scientific Officer	Galien Week of innovation	With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2020	Dennis E. Hruby	SIGA Technologies, Inc.	Chief Scientific Officer	Galien Week of innovation	Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2016	Clifford A. Hudis	the American Society of Clinical Oncology	Chief Executive Officer	Galien Forum USA	Promise - & politics - in the fight against cancer
2020	Mimi Huizinga	Novartis	Vice President & Head, US Oncology Medical	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2020	Mimi Huizinga	Novartis	Vice President & Head, US Oncology Medical	Galien Week of innovation	Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2012	Mark Hulse	Moffitt Cancer Center	RN, Vice President Information Technology & Chief Information Officer,	Galien Forum USA	The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2012	Stephen Hume		Psy.D., Clinician & patient with early onset Alzheimer's disease	Galien Forum USA	Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2022	Robert Iannone	Jazz Pharmaceuticals	Global Head of R&D	Galien Week of Innovation	Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2021	Joseph Illa	Ordre des Medecins - Burkina Faso	Doctor	Galien Forum Africa	Conference on reform in health training
2021	Lucile Imboua	WHO Senegal	Resident Representative	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020	Lucile Imboua	WHO	Resident Representative	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2022	Bev Incledon	Ironshore Pharmaceuticals Inc.	CSO and Executive VP	Galien Week of Innovation	Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2020	Alon Iron	THERANICA	President & Chief Executive Officer, Co-founder	Galien Webinars Series	The digital health enterprise: start-up trends & the culture of big pharma
2021	Melanie Ivarsson	Moderna	Chief Development Officer	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 5
2012	Andrew Jack	Financial Times,	Journalist	Galien Forum USA	Moderator
2021	David Jacoby	BioMarin	Fellow for Clinical Sciences & Vice President Discovery Medicine	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2014	Sachin H. Jain	Merck & Co Inc.; Lecturer in Healthcare Policy, Harvard Medical School	Chief Medical information & Innovation Officer	Galien Forum USA	The future of digital health
2022	Petra Jantzer	Accenture	Senior managing director, global life sciences lead,	Galien Forum USA - Chair	CEO Panel
2021	Ted W. Johnson	Medicinal Chemistry, Pfizer Oncology Pfizer Inc	Research Fellow	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2020	Ted W. Johnson	Medicinal Chemistry, Pfizer Oncology Pfizer Inc.	Research Fellow	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2021	Russ Joseph	Edwards Lifesciences	Senior Director, Product Development, Transcatheter Heart Valves	Galien Week of innovation	How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2013	Kris Joshi	Oracle Health Sciences	Global Vice President, Healthcare	Galien Forum USA	Welcome & intro
2012	Kris Joshi	Healthcare, Oracle Health Sciences	Global Vice President,	Galien Forum USA	Addressing big datachallenges in genomics & personalized healthcare
2021	Marc Julien	Diabeloop	Co-Chief Executive Officer	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021	Carl H. June	Director of Translational Research at the Abramson Cancer Center	the University of Pennsylvania	Galien Forum USA	Where will new therapies & vaccines come from?
2021	Carl H. June	Center for Cellular - Immunotherapies - UPenn	Director	Galien Forum USA	The future is decentralized -- how the paradigm has changed & what it means for modern trials
2021	Anne-Maryse K’Habore	CAMEG	General Manager of CAMEG – SG of ACAME – Burkina Faso	Galien Forum Africa	Youth leadership training (part 1)
2021	Anne-Maryse K’Habore	CAMEG	General Manager of CAMEG – SG of ACAME – Burkina Faso	Galien Forum Africa	Youth leadership training
2021	William G. Kaelin	Harvard Medical School & Dana-Farber Cancer Institute	Sidney Farber Professor of Medicine,	Galien Forum USA	New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2021	Jeanne Kagame	Rwanda	1st Lady of Rwanda	Galien Forum Africa	Closing ceremony
2020	Kenneth Kaitin	Tufts Center for the Study of Drug Development, Tufts University School of Medicine	Director	Jerusalem Ethics Forum	Societal, legal & ethical challenges around access to covid-19 vaccines
2010	Kenneth Kaitin	Tufts Center for the Study of Drug Development	Director	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2021	Amir Kalali	CNS Summit; Decentralized Trials & Researched Alliance;	Chief Currator & Chairman	Galien Webinars Series	Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020	Amir Kalali	CNS Summit; Decentralized Trials & Researched Alliance;	Chief Currator & Chairman	Galien Webinars Series	Digital health in the aftermath of covid-19
2020	Milind Kamkolkar	CELLARITY	Chief Digital & Data Officer	Galien Webinars Series	The digital health enterprise: start-up trends & the culture of big pharma
2020	Eugene Kandel	Start Up Nation Central	Chief Executive Officer	Galien Webinars Series	Digital health in the aftermath of covid-19
2012	Eric Kandel	Department of Neuroscience, Columbia University, New York	Nobel Laureate, Professor & Fred Kavli Professor,	Galien Forum USA	Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2010	Eric Kandel	Columbia University	Nobel Laureate Professor	Galien Forum USA	Translational neuroscience: academic-industrial collaborations in cns diseases
2021	Barinder Kang	Novartis	Vice President & Head, US Oncology Medical (Radio lig& Therapy)	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021	Amadou Kanoute	CICODEV NGO – Senegal	President	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020	Salim Abdool Karim	CAPRISA (South Africa)	Director	Galien Forum Africa	Clinical trials in africa sub-theme 2:
2011	Brian Kaspar	AveXis, Inc	Scientific Founder & Chief Scientific Officer	Galien Forum USA	The promise of gene therapy
2022	Nobuko Kato	Takeda	Vice President, Global Head of External Communications, Corporate Communications & Public Affairs	Galien Webinars Series	Golden Jubilee - Best Orphan Rare Category
2022	Ariel Katz	H1	Co-Founder & CEO	Galien Forum USA	Diversity and health equity in the future creation of medicine
2012	Russell Katz	Division of Neurology Products, Center for Drug Evaluation & Research, Food & Drug Administration	Director	Galien Forum USA	Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2020	Michael Kauffman	Karyopharm Therapeutics Inc	Chief Executive Officer Co-Founder	Galien Week of innovation	Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2022	Paramjit Kaur	Servier Pharmaceuticals	Asset Leader	Galien Week of Innovation	Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence
2022	Patrick J. Kennedy	The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction & the Opioid Crisis; Co-Founder, One Mind; Co-Chair, Mental Health for US	Former U.S. Representative (D-RI); Founder	Galien Forum USA	Mental health in America, a public health crisis
2019	Patrick J. Kennedy	The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction & the Opioid Crisis; Co-Founder, One Mind; Co-Chair, Mental Health for US	Former U.S. Representative (D-RI); Founder	Galien Forum USA	The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2018	Admasu Kesete	RBM end malaria	Chief Executive Officer	Galien Forum Africa	Financing africa’s healthcare
2010	Mark Kessel	Symphony Capital LLC	Managing Director	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2021	Ibrahima Khalilou Dia	e-health Dpt of Ministery of Health & Social Welfare – Senegal	Coordinator	Galien Forum Africa	Innovations & ethic for global health security
2020	Ibrahima Khalilou Dia	e-health Dpt of Ministery of Health & Social Welfare – Senegal	MSAS digital health unit	Galien Forum Africa	What place for digital health & innovations? sub-theme 3:
2010	Kostas Kidos	Oracle Corporation Pharmacovigilance in the Intersection of Healthcare & Life Sciences	Vice President, Safety & PV Strategy	Galien Forum USA	The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2021	George Kimathi	Capacity Building Institute, Amref Health Africa	Director	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2022	Robert Kissling	Bausch + Lomb	VP Medical&Scientific Affairs	Galien Week of Innovation	Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2014	William E. Klitgaard	Covance	Senior Vice President et Information Director	Galien Foum Monaco	Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021	Stephanie Klocke	Becton, Dickinson & Company	Vice President of Research & Development	Galien Week of innovation	How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2020	Stephanie Klocke	Becton, Dickinson & Company	Vice President of Research & Development	Galien Week of innovation	What is medtech innovation doing for patients with specialized needs for treatment?
2022	Volker Knappertz	Aurinia Pharmaceuticals Inc.	Executive VP R&D	Galien Week of Innovation	Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2012	Jean-Pierre A. Kocher	The Bioinformatics Core (BIC) of the Mayo Clinic	Head	Galien Forum USA	Addressing big datachallenges in genomics & personalized healthcare
2020	Robert Kowal	Medtronic	Chief Medical Officer, Vice President of Medical Affairs & Business Development	Galien Week of innovation	How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2015	Adrian R. Krainer	Cold Spring Harbor Laboratory, Watson School of Biological Sciences	St. Giles Foundation Professor of Molecular Genetics, Program Chair, Cancer & Molecular Biology,	Galien Forum USA	Spinal muscular atrophy: charting the pathway to clinical progress
2022	Nikolaus Krall	Exscientia	VP, Precision Medicine	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Florian Krammer	Icahn school of medicine at mount Sinai	Pofessor of microbiology, pathology, molecular and cell based medicine,	Galien Forum USA	Covid pandemic science 2022: current vaccines and treatments and the future outlook
2022	Daniella Kranjac	Dynamk Capital LLC	Founding Partner	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2017	Jörg Kreuzer	Boehringer Ingelheim Pharma GmbH & Co. KG	Therapeutic Area Head Medicine CV	Galien Forum USA	Atrial fibrillation
2012	Health Sciences Global Business Unit Kridel	Ferghana Partners	Partner	Galien Forum USA	The changing face of chinese healthcare
2013	Mark Kris	Memorial Sloan-Kettering Cancer Center	Chair Chief, Thoracic Oncology Services,	Galien Forum USA	Oncology: newer therapies
2017	Jim Krueger	Rockefeller University	Laboratory for Investigative Dermatology,	Galien Forum USA	Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2018	Seema Kumar	Johnson & Johnson	Vice President	Galien Forum Africa	Plenary Panel - women in stem in africa
2021	Pradip Kumar Sasmal	Dr. Reddy’s Laboratories	Vice President & Head of CMC, Differentiated Products	Galien Week of innovation	What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2021	Angella Kyomugisha	Women Innovators Incubator program	Participant	Galien Forum Africa	Women & stem in the global health security context
2018	Paul Lalvani	Empower School of Health, India	Dean & Director	Galien Forum Africa	Universal access to essential & others medicines
2016	Story Landis	National Institute of Neurological Disorders & Stroke, National Institutes of Health (NIH), NIH BRAIN Initiative	Former Director, & Co-Founder	Galien Forum USA	Spinal muscular atrophy: charting the pathway to clinical progress
2022	Martin Landray	Oxford University	Professor of Medicine & Epidemiology	Galien Forum UK	Clinical trials & regulations: what have we learned from covid?
2021	Robert S. Langer	David H. Koch Institute MIT	Professor	Galien Week of innovation	What is med tech innovation doing for patients with specialized needs for treatment?
2020	Robert S. Langer	David H. Koch Institute MIT	Professor	Galien Week of innovation	What is medtech innovation doing for patients with specialized needs for treatment?
2018	Robert S. Langer	Massachusetts Institute of Technology	Professor	Galien Forum USA	Novel approaches to combatting opioid addiction
2015	Robert S. Langer	Massachusetts Institute of Technology	Professor	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2021	Peter Langmuir	Incyte	Group Vice President of Oncology Targeted Therapeutics	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2022	Jacob LaPorte	Novartis Pharmaceuticals Corporation	Co-Founder, Global Head	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2020	Margaret Lartey	Ghana	Dean of the Faculty of Medicine	Galien Forum Africa	Place of women in innovation related to covid 19 sub-theme 2:
2012	Martin Leach	Broad Institute, MIT & Harvard	Chief Information Officer,	Galien Forum USA	Addressing big datachallenges in genomics & personalized healthcare
2013	John Lechleiter	Eli Lilly & Company	Chairman & Chief Executive Officer	Galien Forum USA	Affordable care act us healthcare in transition: the stakes for industry
2022	Matthieu Leclerc-Chalvet	Therapixel	CEO	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021	Matthieu Leclerc-Chalvet	Therapixel	Chief Executive Officer	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Melissa Lederer	mHUB	Chief Experience Officer	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2022	Myrto Lee	BCG	Managing Director & Partner	Galien Forum UK	Clinical trials & regulations: what have we learned from covid?
2022	Patrice A. Lee	Pfizer Inc.	VP Pharmaco Exploratory Devt	Galien Week of Innovation	Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2021	Philina Lee	Blueprint Medicines	Senior Vice President, Head of Portfolio Strategy	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2016	Jonathan S. Leff	Deerfield Institute	Partner, Deerfield Management; Chairman,	Galien Forum USA	Next generation antimicrobials – shaping policy to develop new business models
2013	Jeffrey Leiden	Vertex	Chairman, President & Chief Executive Officer	Galien Forum USA	Improving efficiency in drug development
2022	Arjen Lemmen	Argenx	VP, Corporate Devt & Strategy	Galien Week of Innovation	BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2020	David J. Lennon	Novartis Gene Therapies	President	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2016	John Leonard	Intellia Therapeutics	President and Chief Executive Officer	Galien Forum USA	Molecular scissors: what can we expect from gene editing?
2020	Jean Leonetti	Sophia Antipolis Urban Community	President	Jerusalem Ethics Forum	Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2015	Nick Leschly	Bluebird	President & Chief Executive Officer	Galien Forum USA	Delivering on the patient promise of gene therapy
2021	Steven J. Lester	Mayo Clinic-ASU MedTech Accelerator & Professor of Medicine	Chief Medical Officer	Galien Week of innovation	How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2020	Steven J. Lester	Mayo Clinic-ASU MedTech Accelerator	Chief Medical Officer	Galien Week of innovation	How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2021	Franck Leveiller	Alcon	Senior Vice President, Head, Global Research & Development	Galien Week of innovation	What is med tech innovation doing for patients with specialized needs for treatment?
2022	Gail D. Lewis	Genentech	Senior Principal Scientist	Galien Week of Innovation	Laureates Media Presentation
2020	Tanya Lewis	Scientific American	Associate Editor for Health & Medicine	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2020	Dean Y Li	Merck & Co., Inc.	Senior Vice President - Discovery Sciences & Translational Medicine -	Galien Forum USA	The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2013	Richard Lifton	Yale University School of Medicine	Professor	Galien Forum USA	Personalized medicine: effect on drug r&d & patient care
2018	Dan R. Littman	Vedanta Biosciences	Co-Founder	Galien Forum USA	The gut microbiome: opportunities & challenges
2017	Dan R. Littman	American Association of Immunology	Former President	Galien Forum USA	Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2010	Rodolfo R. Lliná S	New York University	Chairman Department of Physiology & Neuroscience	Galien Forum USA	Translational neuroscience: academic-industrial collaborations in cns diseases
2014	Donald Lloyd-Jones	Northwestern University in Chicago.	Chairman of the Department of Preventive Medicine	Galien Forum USA	Heart attack guidelines
2011	Peter D. Loftus	contributor to Wall Street Journal	Dow Jones Newswires reporter covering pharmaceutical industry;	Galien Forum USA	Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2022	Sylvie Lombardi	BD	Director of R&D	Galien Week of Innovation	Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2012	Roger Longman	Real Endpoints	Chief Executive Officer	Galien Forum USA	Moderator
2011	Roger Longman	Real Endpoints	Chief Executive Officer	Galien Forum USA	What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2010	Roger Longman	Real Endpoints	Chief Executive Officer	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2022	Michelle Longmire	Medable	Chair of the Board - President & Chief Executive Officer	Galien Forum USA	Covid pandemic science 2022: current vaccines and treatments and the future outlook
2021	Michelle Longmire	Medable	Chair of the Board - President & Chief Executive Officer	Galien Webinars Series	The incubators of innovation: academic medical centers as digital health champions
2021	Michelle Longmire	Medable	Chair of the Board - President & Chief Executive Officer	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Michelle Longmire	Medable	Co-founder & CEO, Moderator	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Carole Longson	Medicines Discovery Catapult	Vice Chair	Galien Forum UK	Access to innovation: optimizing health for patient populations
2012	William Looney	Executive Magazine	Editorial Director Pharmaceutical	Galien Forum USA	Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2013	Jan Lundberg	Lilly Research Labs, Lilly & Co.	Executive Vice President, Science & Technology & President	Galien Forum USA	Improving efficiency in drug development
2022	Lusong Luo	BeiGene	Senior VP, External Innovation	Galien Week of Innovation	Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2021	Crystal L. Mackall	Ernest & Amelia Gallo Family, Stanford University	Professor of Pediatrics & Internal Medicine	Galien Forum USA	New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2015	Charles R. Mackay	Pfizer Inc.	Inflammation & Immunology,	Galien Forum USA	Microbiota in human diseases
2016	Sandi Macrae	Sangamo BioSciences	President & Chief Executive Officer	Galien Forum USA	Molecular scissors: what can we expect from gene editing?
2021	Serigne Magueye Gueye	Campus franco-senegalais – Senegal	Director General	Galien Forum Africa	Conference on reform in health training
2021	Sadiqa Mahmood	Health Catalyst	General Manager & Senior Vice President Life Science Business	Galien Webinars Series	Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2021	Aliou Maïga	West & Central Africa of the International Finance Corporation IFC	Regional Director	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020	Hilary Malone	Valo Health	Chief Operating Officer	Galien Webinars Series	Digital health improving research & care
2021	El Hadji Mamadou Ndiaye	Prevention at the Ministry of Health & Social Action – Senegal	Director	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020	Flavio Manetlli	Dompe U.S. Inc.	Chief Medical Officer	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2021	Carl Manlan	ECOBANK Foundation – International – Ivory Coast	Director of Operations	Galien Forum Africa	Meeting of young innovators with investors
2020	Carl Manlan	ECOBANK Foundation – International – Ivory Coast	Director of Operations	Galien Forum Africa	Financing the response to covid 19
2020	John Maraganore	Alnylam	Chief Executive Officer	Galien Forum USA	The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2022	Joel S. Marcus	Alexandria real estate equities, inc./Alexandria venture investments	Executive Chairman & Founder Co-Founder,	Galien Forum USA	Mental health in America, a public health crisis
2021	Joel S. Marcus	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit	Chairman, Chief Executive Officer & Founder, Co-Founder	Galien Forum USA	Combating the opioid crisis in america
2020	Joel S. Marcus	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit	Chairman, Chief Executive Officer & Founder, Co-Founder	Galien Forum USA	Covid-19 vaccines: the path to the holy grail
2019	Joel S. Marcus	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Executive Chairman & Founder Co-Founder,	Galien Forum USA	Can disruptive innovation positively impact healthcare costs?
2018	Joel S. Marcus	Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Alexandria Summit	Executive Chairman & Founder Co-Founder,	Galien Forum USA	Cancer in a time of disruption
2017	Joel S. Marcus	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Co-Moderator, Chairman, Chief Executive Officer & Founder, Co-Founder	Galien Forum USA	Addressing unmet medical needs with early-stage life science venture capital
2014	Joel S. Marcus	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit	Chairman, Chief Executive Officer & Founder, Co-Founder	Galien Forum USA	The future of digital health
2013	Joel S. Marcus	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Chairman	Galien Forum USA	Welcome & intro
2012	Joel S. Marcus	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit	Chairman, Chief Executive Officer & Founder, Co-Founder	Galien Forum USA	Welcome Remarks
2021	Yuri Maricich	Pear Therapeutics	Chief Medical Officer & Head of Development	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2020	Yuri Maricich	Pear Therapeutics	Chief Medical Officer & Head of Development	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2016	Michael Mark	Research Boehringer Ingelheim Pharma GmbH & Co. KG Research	Vice President & Global Head of Cardio Metabolic Diseases	Galien Forum USA	Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2021	Wanda Markotter	Centre for Viral Zoonoses Pretoria – South Africa	Director	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 2
2018	Peter Marks	Center for Biologics Evaluation & Research, FDA	Director	Galien Forum USA	The promise of gene therapy
2014	Peter Marks	Center for Biologics Evaluation & Research, FDA	Director	Galien Forum USA	Fireside chat \| delivering on the patient promise of gene therapy
2012	Lynn Marks	Clinical Platforms & Sciences, GlaxoSmithKline plc	Senior Vice President, Projects	Galien Forum USA	Infectious diseases: a global healthcare challenge
2022	Peter Marks	Center for Biologics Evaluation & Research, FDA	Director	Galien Forum USA	Covid pandemic science 2022: current vaccines and treatments and the future outlook
2022	John Martin	Butterfly Network Inc	Chief Medical Officer	Galien Week of Innovation	Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2018	Kelsey C. Martin	Simons Foundation Autism Research Initiative (SFARI)	Director	Galien Forum USA	Cancer in a time of disruption
2010	Sharon Mates	Intra-Cellular Therapies	Chairman & Chief Executive Officer	Galien Forum USA	Translational neuroscience: academic-industrial collaborations in cns diseases
2021	Eric Mayes	Endomagnetics Ltd.	Chief Executive Officer	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2020	Eric Mayes	Endomag Ltd.	Chief Executive Officer	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2015	Sarkis K. Mazmanian	California Institute of Technology	Louis & Nelly Soux Professor of Microbiology	Galien Forum USA	The gut microbiome: opportunities & challenges
2015	Sarkis K. Mazmanian	California Institute of Technology	Louis & Nelly Soux Professor of Microbiology	Galien Forum USA	Microbiota in human diseases
2020	Aminata Mbengue Ndiaye	Territorial Communities HCCT (Senegal)	President High Council	Galien Forum Africa	Africa post covid 19
2021	Souleymane Mboup	IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training)	Executive Director	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2021	Souleymane Mboup	IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training)	Co-President	Galien Forum Africa	Closing ceremony
2020	Souleymane Mboup	IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training)	President & Chief Executive Officer	Galien Forum Africa	Research facing covid 19
2018	Souleymane Mboup	IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training)	Chief Executive Officer	Galien Forum Africa	Remarkable women engage for humanity
2018	Souleymane Mboup	IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training)	Chief Executive Officer	Galien Forum Africa	managing infectious diseases & pandemics
2021	Cheikh Mbow	Future Africa University of Pretoria – South Africa	Director	Galien Forum Africa	Youth leadership training (part 1)
2021	Cheikh Mbow	Future Africa University of Pretoria – South Africa	Director	Galien Forum Africa	Youth leadership training
2020	Cheikh Mbow	Future Africa University of Pretoria (South Africa)	Inaugural Director	Galien Forum Africa	Environmental impact of the covid 19 pandemic sub-theme 4:
2018	Cheikh Mbow	Harvard	Chief Executive Officer	Galien Forum Africa	The health consequences of climate change
2018	Corey McCann	Pear Therapeutics	President & Chief Executive Officer	Galien Forum USA	Novel approaches to combatting opioid addiction
2022	Chrissa McFarlane	Patientory Inc	CEO	Galien Week of Innovation	Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2021	Chrissa McFarlane	Patientory Inc.	Founder & Chief Executive Officer	Galien Week of innovation	Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2016	Mark McLellan	Professor of Business, Medicine, & Health Policy, Duke-Robert J. Margolis Center for Health Policy & Robert J. Margolis, Duke University	Director	Galien Forum USA	Next generation antimicrobials – shaping policy to develop new business models
2014	Mark McLellan	the Brookings Institution	Senior Fellow & Director of the Health Care Innovation & Value Initiative	Galien Forum USA	Us health reform
2021	Sapna McManus	Genentech	Head of Patient Inclusion & Health Equity, Chief Diversity Office	Jerusalem Ethics Forum	Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2015	Michelle McMurry-Heath	BIO	President & Chief Executive Officer	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2018	Nicolas Meda	Burkina Faso	Minister ofHealth	Galien Forum Africa	managing infectious diseases & pandemics
2018	Nicolas Meda	Burkina Faso	Minister of Health	Galien Forum Africa	Remarkable women engage for humanity
2022	Gerold Meinhardt	Daiichi Sankyo	Vice President, Asset & Portfolio Management	Galien Week of Innovation	Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2015	Ira Mellman	Genentech	Vice President, Research Oncology,	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2022	Johanna Mercier	Gilead Sciences	Chief Communications Officer	Galien Webinars Series	Golden Jubilee - Best Orphan Rare Category
2020	Jane Metcalfe	Neo.Life. Wired Magazine	Chief Executive Officer Co-Founder	Galien Webinars Series	Digital health in the aftermath of covid-19
2022	Philippe Michel	FUTURE4CARE	COO	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020	Jennifer Miller	Yale School of Medicine	Assistant Professor	Jerusalem Ethics Forum	Tracking bioethics: transparency, trust & the industry’s social imperatives
2011	Steve Miller	Express Scripts	Senior Vice President & Chief Medical Officer	Galien Forum USA	Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2019	Talya Miron-Shatz	Israel	Decision Scientist	Jerusalem Ethics Forum	Human reproduction: technical limit, ethical limit
2021	Kenneth I. Moch	Center for Global Health Innovation & Global Health Crisis Coordination Center	Senior Advisor to the Chairman	Jerusalem Ethics Forum	Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2020	Kenneth I. Moch	Center for Global Health Innovation & Global Health Crisis Coordination Center	Senior Advisor to the Chairman	Jerusalem Ethics Forum	Societal, legal & ethical challenges around access to covid-19 vaccines
2021	Serigne Modou Babou	Cauris technologiesUniversité Cheikh Anta Diop de Dakar	Professor	Galien Forum Africa	Conference on reform in health training
2022	Alexandra Moens	H1	Dir Product Marketing - Moderator	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Alexandra Moens	H1	Dir Product Marketing - Moderator	Galien Week of Innovation	Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2022	Alexandra Moens	H1	Dir Product Marketing Moderator	Galien Week of Innovation	BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021	Matshidiso Moeti	WHO Regional Office for Africa	Regional Director	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 3
2021	Matshidiso Moeti	WHO Regional Office for Africa	Regional Director	Galien Forum Africa	Closing ceremony
2020	Matshidiso Moeti	WHO Regional Office for Africa	Regional Director	Galien Forum Africa	The response of african countries to the covid-19 pandemic
2020	Matshidiso Moeti	WHO Regional Office for Africa	Regional Director	Galien Forum Africa	Africa post covid 19
2018	Matshidiso Moeti	WHO Regional Office for Africa	Regional Director	Galien Forum Africa	Which plan for non communicable diseases?
2021	Mark Mogul	Servier Pharmaceuticals	Head of Medical Affairs	Galien Week of innovation	Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2020	Briggs Morrison	Syndax	Chief Executive Officer	Jerusalem Ethics Forum	Tracking bioethics: transparency, trust & the industry’s social imperatives
2020	Ponda Motsepe – Ditshego	Amgen Bone	Executive Medical Director	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2018	Aaron Motsoaledi	South Africa	Minister of Health	Galien Forum Africa	Financing africa’s healthcare
2020	Vanessa Moungar	African Development Bank (Chad)	Director of Gender & Civil Society	Galien Forum Africa	Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2022	Katherine Moyer	Skipta	VP Content & Com - Moderator	Galien Week of Innovation	Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2022	Shephard Mpofu	Novartis Gene Therapies	SVP, CMO	Galien Week of Innovation	BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021	Shephard Mpofu	Novartis	Senior Vice President & Chief Medical Officer	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2021	Arnold Munnich	Hopital Necker Enfants Malades	Chief of Dpeartment	Galien Webinars Series	The impact of digital technology in clinical trials: ethical considerations (french edition)
2020	Arnold Munnich	University Paris-Descartes, France	Genetics	Jerusalem Ethics Forum	Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2019	Arnold Munnich	University Paris-Descartes, France	Genetics	Jerusalem Ethics Forum	Personalized genomics medicine: the value of knowing
2019	Arnold Munnich	University Paris-Descartes, France	Genetics	Jerusalem Ethics Forum	2020/2030 agenda “facing the next ethical challenges”
2021	Terry Murphy	Janssen	COVID-19 Clinical Dev. Relaunch Leader	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-21
2016	John Mc Murray	Institute of Cardiovascular & Medical Sciences, University of Glasgow	Professor of Medical Cardiology,	Galien Forum USA	Keynote
2015	John Mc Murray	Institute of Cardiovascular & Medical Sciences, University of Glasgow	Professor of Medical Cardiology,	Galien Forum USA	Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2019	Mordechai Muszkat	Hadassah University Hospital at Mt Scopus, Israel	Head of the Department of Medicine	Jerusalem Ethics Forum	Health policy & financing innovation: ethical considerations, cost & the role of the patient
2021	John Mwangi	Daktari Media	Chief Executive Officer	Galien Forum Africa	Leadership & innovation, meet the winners of the africa young innovators award for health
2021	Whitney Mwangui	African Union	Advocacy, Partnership & Communication Specialist	Galien Forum Africa	Leadership & innovation, meet the winners of the africa young innovators award for health
2015	Elizabeth Nabel	Brigham & Women’s Hospital	President	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2021	Mame Nahe Diouf	Institute of Agricultural Research (ISRA), National Laboratory of Livestock & Veterinary Research (LNERV) – Senegal	Director	Galien Forum Africa	Involvement of women researchers in the mhw
2015	Gerard Nahum	Bayer Pharmaceuticals	Vice President, Global Clinical Development for Medical Devices & eHealth,	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2021	Nuriat Nambogo	Women Innovators Incubator program	Participant	Galien Forum Africa	Women & stem in the global health security context
2014	Tara Narula	CBS This Morning	Medical Contributor,	Galien Forum USA	Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2015	Ameet Nathwani	Novartis	Senior Vice President & Global Head of Medical Affairs.	Galien Forum USA	Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2018	Sidy Ndao	University of Nebraska-Lincoln - USA	Associate Professor,	Galien Forum Africa	Plenary Panel - women in stem in africa
2021	Massamba Ndiaye	Ubuntu University, National Digital Debate of the Youth	Founder Executive Chairman	Galien Forum Africa	Youth leadership training (part 1)
2021	Massamba Ndiaye	Ubuntu University, National Digital Debate of the Youth	Founder Executive Chairman	Galien Forum Africa	Youth leadership training
2020	Youssou Ndiaye	MSAS- Senegal	Director of Planning, Research & Statistics	Galien Forum Africa	Health & socio-economic impact of the covid 19 pandemic in africa sub-theme 1: resilience of health systems & continuity of care: state of play, challenges & rerspectives
2018	Alioune Ndiaye	UN	Special Advisor	Galien Forum Africa	The health consequences of climate change
2021	Aïta Ndir Dia	WERGU – Senegal	Co-founder	Galien Forum Africa	Meeting of young innovators with investors
2021	Babacar Ndoye	WHO Expert-Consultant Senegal	Expert-Consultant	Galien Forum Africa	« one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2018	Lee N. Newcomer	UnitedHealthcare	Principal, Lee Newcomer Consulting LLC, Former Senior Vice President, Oncology & Genetics,	Galien Forum USA	Cancer in a time of disruption
2014	William Newsome	Stanford University of Medicine	Ph.D. Harman Family Provostial Professor & Professor of Neurobiology,	Galien Forum USA	The brain initiative
2021	Sobel Ngom	Consortium Jeunesse Senegal	Executive Director	Galien Forum Africa	Meeting of young innovators with investors
2020	Sobel Ngom	Social change Factory	Executive Director	Galien Forum Africa	Youth forum: leadership & young people facing covid-19
2018	Mabingue Ngom	WCARO (Western & Central Africa Region), UNFPA	Regional Director	Galien Forum Africa	Universal access to essential & others medicines
2020	Marie Khemesse Ngom Ndiaye	National Committee for the Management of Epidemics (Senegal)	Director General of Health & President	Galien Forum Africa	Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2021	Catherine Nguila	Winner of the L’Oreal /Unesco Africa Prize for Women in Science – Kenya	Winner of the L’Oreal /Unesco Africa Prize	Galien Forum Africa	Involvement of women researchers in the mhw
2018	Mary Teuw Niane	Research & Innovation, Senegal	Minister of Higher Education	Galien Forum Africa	Plenary Panel - women in stem in africa
2020	Cheikh Ibrahima Niang	FST	Socio-anthropologis	Galien Forum Africa	Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4:
2011	Steven Nissen	Clevel& Clinic Lerner School of Medicine at Case Western Reserve U	Chairman, Department of Cardiovascular Medicine Clevel& Clinic Foundation & Professor of Medicine,	Galien Forum USA	Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2022	Wilfred Njagi	Villgro Africa	CEO	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2021	John Nkengasong	African Centers for Disease Control & Prevention (CDC Africa) President the Prix Galien Africa Jury International – Cameroon	Director	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 4
2021	John Nkengasong	African Centers for Disease Control & Prevention (CDC Africa) President the Prix Galien Africa Jury International – Cameroon	Director	Galien Forum Africa	Closing ceremony
2021	John Nkengasong	Prix Galien Africa Jury International – Cameroon	CDC Africa Director	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020	John Nkengasong	African Centers for Disease Control & Prevention (Africa CDC)	Director	Galien Forum Africa	The response of african countries to the covid-19 pandemic
2020	John Nkengasong	African Centers for Disease Control & Prevention (Africa CDC)	Director	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2018	John Nkengasong	CDC, Centre for Disease Control & Prenvention, Africa	Director	Galien Forum Africa	Remarkable women engage for humanity
2018	John Nkengasong	Centre for Disease Control & Prenvention - Africa	Director	Galien Forum Africa	managing infectious diseases & pandemics
2011	Larry Norton	Memorial Sloan-Kettering Cancer Center	Deputy physician-in chief for breast cancer programs & medical director, Evelyn H. Lauder Breast Center,	Galien Forum USA	Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2020	Ngoy Nsenga	COVID 19 & Program Manager for Emergency Response at WHO AFRO	Incident Manager	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2021	Francine Ntoumi	Congolese Foundation for Medical Research (DR Congo)	President & Executive Director	Galien Forum Africa	Involvement of women researchers in the mhw
2021	Mwelecele Ntuli Malecela	Deportment of Control of Neglected Tropical Diseases World Health Organization	Director	Jerusalem Ethics Forum	Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2015	Stephen Oesterle	Medtronic, plc	Senior Vice President Medicine & Technology	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2019	Joshua J. Ofman	GRAIL, Inc	Chief of Corporate Strategy & External Affairs	Galien Forum USA	Digital health -orchestrating patient- centricity from molecule to market
2021	Stephen Ogweno	Stowelink Inc. – Kenya	Young Innovators	Galien Forum Africa	Meeting of young innovators with investors
2021	Franz Okey	Speak Up Africa Country Coordinator in Benin – Benin	Country Coordinator	Galien Forum Africa	The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2021	Ngozi Okonjo-Iweala	World Trade Organization WTO – International – Nigeria	Director General	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2011	Bernat Olle	Vedanta Biosciences	Chief Executive Officer	Galien Forum USA	The gut microbiome: opportunities & challenges
2021	Olayinka Olusola Omigbodun	Representative of the Deans of ECOWAS-Nigeria	Provost University of Ibadan, Representative of the Deans of ECOWAS	Galien Forum Africa	Youth leadership training (part 1)
2021	Olayinka Olusola Omigbodun	Representative of the Deans of ECOWAS-Nigeria	Provost University of Ibadan, Representative of the Deans of ECOWAS	Galien Forum Africa	Youth leadership training
2020	Olayinka Olusola Omigbodun	University of Ibadan (Nigeria)	Dean of the College of Medicine	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2020	Francis Omaswa	African Center for Global Health & Social Transformation; 2019 NOGUCHI Prize Laureate (Ug& a)	Executive Director	Galien Forum Africa	Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4:
2020	Jorge Ortiz	Bayer	Global Medical Affairs Head	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2021	Anu Osinusi	Gilead Sciences	Vice President, Clinical Research for Hepatitis, Respiratory & Emerging Viruses	Galien Week of innovation	With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2021	Cheikh Oumar Seydi	Bill & Melinda Gates Foundation Africa	Scientific Advisory Committee	Galien Forum Africa	Innovations & ethic for global health security
2022	Jackie Pacelli	AbbVie	VP, Communications	Galien Webinars Series	Golden Jubilee - Best BioTech Category
2012	Michel Pairet	Boehringer Ingelheim	Member, Board of Managing Directors - Innovation,	Galien Forum USA	Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020	Alexandra Palt	L’Oreal FoundationFrance	President	Galien Forum Africa	Place of women in innovation related to covid 19 sub-theme 2:
2022	Susan Pandya	Servier Pharmaceuticals	Clin. Devt Head of Cancer	Galien Week of Innovation	Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2022	Menelas (Mene) Pangalos	AstraZeneca	Executive Vice President & President BioPharmaceuticals R&D	Galien Forum UK	Clinical trials & regulations: what have we learned from covid?
2014	Ed Park	Athenahealth, Inc	Executive Vice President & Chief Operating Officer	Galien Forum USA	The future of digital health
2012	Roy Parker	University of Colorado, Boulder	Professor Cech-Leinwand Endowed Chair of Biochemistry	Galien Forum USA	Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020	Amanda Paschke	Merck & Co., Inc.	Executive Director Global Clinical Development	Galien Week of innovation	Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2011	Richard C. Pasternak	Merck & Co., Inc	Former Vice-President & Past Director	Galien Forum USA	What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021	Muhammad Ali Pate	Harvard University Former Minister of Health (Nigeria/ USA)	Public Health Leadership	Galien Forum Africa	Women’s leadership in global health security
2020	Muhammad Pate	World Bank	Public Health Leadership	Galien Forum Africa	Financing the response to covid 19
2022	Kiran Patel	Janssen	VP Clinical Devt, Solid Tumor	Galien Week of Innovation	Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2015	Steven Paul	Voyager Therapeutics	President & Chief Executive Officer	Galien Forum USA	Untangling the web of neurodegeneration: how far & how soon?
2021	Eric M Pearlman	Eli Lilly & Company	Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs	Galien Week of innovation	What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2020	Eric M Pearlman	Eli Lilly & Company	Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2020	Eric M Pearlman	Eli Lilly & Company	Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs	Galien Week of innovation	The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2011	Steve Pearson	Institute for Clinical & Economic Review (ICER)	Founder & President	Galien Forum USA	Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2019	Renzo Pegoraro	Lanza Foundation, Vatican	Scientific Director	Jerusalem Ethics Forum	Human reproduction: technical limit, ethical limit
2021	Louis Penali	Life Sciences Ethics Committee, Cote d’Ivoire, MSF Scientific Advisor (West & Central Africa) International – Côte d’Ivoire	President	Galien Forum Africa	Innovations & ethic for global health security
2022	Rodolfo Perini	Merck & Co., Inc	AVP Global Clinical Dvt Onco	Galien Week of Innovation	Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2021	Greg Perry	IFPMA	Assistant Director-General	Galien Forum Africa	Women & stem in the global health security context
2011	Magnus Persson	The Column Group	Managing Partner	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2012	Jennifer C. Petter	Arrakis	Founder & Chief Scientific Officer	Galien Forum USA	Drugging the undruggable» with novel approaches to small molecule design
2010	Seth Pinsky	New York City Economic Development Corporation (NYCEDC)	President	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2011	Gary Pisano	Harvard Business School	Harry E. Figgie Professor of Business Administration,	Galien Forum USA	Making medicines affordable
2011	Peter J. Pitts	Center for Medicine in the Public Interest	President	Galien Forum USA	What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021	David Platt	Novartis Pharmaceuticals Corporation	Vice President, Medical Unit Head Cardiovascular, Renal & Metabolism Medical Unit	Galien Week of innovation	What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2020	David Platt	Novartis Pharmaceuticals Corporation	Vice President, Medical Unit Head Cardiovascular, Renal & Metabolism Medical Unit	Galien Week of innovation	The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2012	Andy Plump	Takeda Pharmaceuticals Company Ltd	President, Research & Development,	Galien Forum USA	Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2022	Theresa Podrebarac	Horizon Therapeutics	SVP Clinical Devt	Galien Week of Innovation	Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2018	Marie-Pierre Poirier	WCA (Western & Central Africa) UNICEF	Regional Director	Galien Forum Africa	Addressing chronic malnutrition
2022	Catherine Pollard	Centre for Improving Data Collaboration, NHSX	Director	Galien Forum UK	Digital health innovation: a key driver of next generation healthcare – what & when?
2012	Richard F. Pops	Alkermes	Chairman & Chief Executive Officer	Galien Forum USA	Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2012	William Potter	National Institute of Mental Health	Senior Advisor,	Galien Forum USA	Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2013	John Thomas Potts, Jr	Massachusetts General Hospital & Harvard Medical School	Distinguished Jackson Professor of Clinical Medicine,	Galien Forum USA	The promise of gene therapy
2022	Bernard Poussot	Roche holding & Wyeth	Director & Former Chairman & CEO	Galien Forum USA - Chair	prix Galien awards ceremony categories: > best startup > best digital health solution > inaugural best incubator/accelerator/equity
2020	Santosh Prabhu	Abbott Structural Heart	Divisional Vice President, Product Development	Galien Week of innovation	How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2021	Lisa Prasad	Henry Ford Health System	Vice President & Chief Innovation Officer	Galien Webinars Series	The incubators of innovation: academic medical centers as digital health champions
2022	David Prior	NHS England	Lord.	Galien Forum UK	Access to innovation: optimizing health for patient populations
2012	Stanley Prusiner	University of California, San Francisco (UCSF)	Nobel Laureate, Professor of Neurology & Biochemistry,	Galien Forum USA	Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020	Dee Punungwe	Kenya	researcher	Galien Forum Africa	Place of women in innovation related to covid 19 sub-theme 2:
2010	Dennis Purcell	Aisling Capital	Senior Managing Director	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2011	Mark Pykett	Neoprobe Corporation	President & Chief Executive Officer	Galien Forum USA	Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2011	Paul I. Rachlin	Proskauer	Partner	Galien Forum USA	Funding innovation new trends in the healthcare m&a l& scape
2020	Angela Radcliffe	CAPGEMINI INVENT	R&D Practice Lead,m Founding Member, CoS, IEEE Global Initiative to Standardize Fairness in the Trade of Data; Advisory Board Member to Startups in Life Science; Clinical Research Advocate	Galien Webinars Series	The digital health enterprise: start-up trends & the culture of big pharma
2014	Daniel Rader	the University of Pennsylvania	Medicine	Galien Forum USA	Heart attack guidelines
2020	Sri Radhakrishnan	Pulmonx Corporation	Chief Technical Officer	Galien Week of innovation	What is medtech innovation doing for patients with specialized needs for treatment?
2022	Maha Radhakrishnan	Biogen	Group senior vice president & chief medical officer	Galien Forum USA	Diversity and health equity in the future creation of medicine
2021	Charlemagne Marie Ragnag-Newende Ouedraogo	Burkina Faso	Minister of Health	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 5
2022	June Raine	MHRA	Chief Executive Officer	Galien Forum UK	Clinical trials & regulations: what have we learned from covid?
2020	Jean-Daniel Rainhorn	Geneva University/IHEID, Switzerland	Honorary Professor in International Health & Humanitarian Action	Jerusalem Ethics Forum	Up-to-date reflection on society, medicine & reproduction
2019	Jean-Daniel Rainhorn	Geneva University/IHEID, Switzerland	Honorary Professor in International Health & Humanitarian Action	Jerusalem Ethics Forum	Health policy & financing innovation: ethical considerations, cost & the role of the patient
2022	Reshma Rangwala	Karyopharm Therapeutics Inc.	CMO	Galien Week of Innovation	Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence
2020	Ishu Rao	Impulse Dynamics	Medical Director	Galien Week of innovation	How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2022	Simon Rasalingham	behold.ai	CEO and Chairman	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2012	Guido Rasi	European Medicines Agency	Executive Director	Galien Forum USA	Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2012	Guido Rasi	European Medicines Agency	Executive Director	Galien Forum USA	21st century science: building partnerships, managing for success
2020	Mads Frederik Rasmussen	Novo Nordisk A/S	Corporate Project Vice President for GLP-1, CV & Outcomes	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2019	Franklin Rausky	Elie Wiesel Institute, France	Director of Jewish Studies	Jerusalem Ethics Forum	Life sciences: psychiatry, humanism & totalitarianism
2022	Lynn Ray	Olympus America Inc.	VP, GM, Global Respiratory Olympus	Galien Week of Innovation	Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2017	Vivek Reddy	Icahn School of Medicine, Mount Sinai	Leona M. & Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology,	Galien Forum USA	Atrial fibrillation
2022	Andy Richards	Congenica Ltd, Owlstone Medical, Closed Loop Medicine & ieso Digital Health	CBE I Chair	Galien Forum UK	Digital health innovation: a key driver of next generation healthcare – what & when?
2021	Valery Ridde	IRD,Montreal-Canada	Teacher	Galien Forum Africa	« one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2015	Robert H. Ring	Autism Speaks	Chief Executive Officer	Galien Forum USA	Autism - the next decade
2021	Michael Ringel	BCG	Managing Director & Senior Partner	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2020	Michael Ringel	BCG	Managing Director & Senior Partner	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2011	Michael Ringel	BCG	Managing Director & Senior Partner	Galien Forum USA	Drugging the undruggable» with novel approaches to small molecule design
2022	Michael Ringel	BCG	Managing Dir Sr Partner - Moderator	Galien Week of Innovation	Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2021	Maryanne Rizk	Medable	Chief Strategy Officer	Galien Forum USA	The future is decentralized -- how the paradigm has changed & what it means for modern trials
2020	Maryanne Rizk	IQVIA	Senior Vice President, R&D Digital Strategy	Galien Week of innovation	Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2019	Maryanne Rizk	IQVIA	Senior Vice President, R&D Digital Strategy	Galien Forum USA	Digital health -orchestrating patient- centricity from molecule to market
2016	Maryanne Rizk	Oracle Health Sciences	Senior Vice President, R&D Digital Strategy	Galien Forum USA	Molecular scissors: what can we expect from gene editing?
2015	Maryanne Rizk	Oracle Health Sciences	Senior Vice President, R&D Digital Strategy	Galien Forum USA	Autism - the next decade
2022	Samantha Roberts	NICE	Chief Executive Officer	Galien Forum UK	Access to innovation: optimizing health for patient populations
2021	Antoine Rodrigue	MODJAW	Chief Executive Officer	Galien Week of innovation	In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022	Sandy Rodriguez	Roche	Vice President, Communications	Galien Webinars Series	Golden Jubilee - Best BioTech Category
2011	Kent Rogers	UnitedHealth Group Inc	M.B.A., Senior Vice President, Industry Relations,	Galien Forum USA	Making medicines affordable
2011	Dana Rollison	Moffitt Cancer Center	Vice President, Total Cancer Care & Chief Health Information Officer,	Galien Forum USA	The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2013	Maria Grazia Roncarolo	Stanford University	Professor of Pediatrics & Medicine,	Galien Forum USA	Fireside chat \| delivering on the patient promise of gene therapy
2019	Steve Rosenberg	Oracle Health Sciences	Senior Vice President & General Manager	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2013	Steve Rosenberg	Oracle Health Sciences	Senior Vice President & General Manager,	Galien Forum USA	The marriage of technology & medicine: bringing out the best in each other
2022	Michael Rosenblatt	Galien Forum & flagship pioneering	Co-Chair & Senior Partner	Galien Forum USA	Welcome
2022	Michael Rosenblatt	Galien Foundation	Committee Chair	Galien Week of Innovation	Laureates Media Presentation
2021	Michael Rosenblatt	Flagship Pioneering	Senior Partner	Galien Week of innovation	Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions?
2021	Michael Rosenblatt	Flagship Pioneering	Galien Forum Co-Chair Senior Partner	Galien Forum USA	Welcome
2020	Michael Rosenblatt	Flagship Pioneering	Chief Medical Officer, Co-Chair: Galien Forum	Galien Forum USA	The promise of gene therapy
2020	Michael Rosenblatt	Flagship Pioneering	Chief Medical Officer	Galien Forum USA	The next 50 years of innovation: where will it come from & how do we secure it?
2020	Michael Rosenblatt	Flagship Pioneering	Chief Medical Officer	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2020	Michael Rosenblatt	Flagship Pioneering	Chief Medical Officer	Galien Forum USA	Making medicines affordable
2013	Michael Rosenblatt	Merck & Co., Inc.	Executive Vice President & Chief Medical Officer	Galien Forum USA	The promise of gene therapy
2012	Michael Rosenblatt	Merck & Co., Inc.	Executive Vice President & Chief Medical Officer	Galien Forum USA	Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2011	Michael Rosenblatt	Merck & Co., Inc.	Executive Vice President & Chief Medical Officer	Galien Forum USA	Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2020	Kate Rosenbluth	Cala Health	Founding Chief Executive Officer & Chief Scientific Officer	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2019	Michal Rosen-Zvi	IBM, Israel	Director of Health Informatics	Jerusalem Ethics Forum	“artificial intelligence & ethics”
2014	Hans Rosling	Karolinska Institutet, Sweden	Global Health	Galien Forum USA	A new agenda for global health
2020	Joseph Ross	Yale School of Medicine	Medicine & Public Health	Jerusalem Ethics Forum	Tracking bioethics: transparency, trust & the industry’s social imperatives
2021	Scott T. Rottinghaus	Alexion Pharmaceuticals	Vice President, Head of Clinical Development, Hematology & Nephrology	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2015	John W. Rowe	the Columbia University Mailman School of Public Health	Julius B. Richmond Professor of Health Policy & Aging	Galien Forum USA	Us health reform: partnering, pricing & politics
2011	Francesco Rubino	Metabolic & Diabetes Surgery Center, Weill Cornell Medical College	Associate Professor of Surgery, Director,	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2020	Marcella Ruddy	Regeneron	Vice President, Strategic Program Direction, Immunology & Inflammation	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2021	Rodrigo Ruiz Soto	Deciphera	Senior Vice President, Clinical Development & Translational Medicine	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021	Renee Ryan	Cala Health	Chief Executive Officer	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2022	Renee Ryan,	Cala Health	CEO	Galien Week of Innovation	Laureates Media Presentation
2017	Lars Ryden	Karolinska Institute, Stockholm, Sweden	Senior Professor of Cardiology	Galien Forum USA	Atrial fibrillation
2016	Lars Ryden	Karolinska Institute, Stockholm, Sweden	Senior Professor of Cardiology	Galien Forum USA	Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2015	Lars Ryden	Karolinska Institutet, Stockholm, Sweden	Senior Professor of Cardiology	Galien Forum USA	Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2016	Michel Sadelain	Center for Cell Engineering, Memorial Sloan Kettering Cancer Center	Director	Galien Forum USA	Precision medicine: delivering on the promise
2021	Jim Sailer	Population Council	Executive Director, Center for Biomedical Research	Galien Week of innovation	With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2020	Abdou Salam Fall	Economic & Social Transformations (LARTES) (Senegal)	Director of the Research Laboratory	Galien Forum Africa	Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2019	Ayman Salem	USA	Neurosurgeon	Jerusalem Ethics Forum	“artificial intelligence & ethics”
2021	Papa Salif Sow	Africa Health Department, Mastercard Foundation	Director	Galien Forum Africa	Meeting of young innovators with investors
2020	Ndeye Salimata Diop Dieng	Family, Gender & Child Protection (Senegal)	Minister of Women	Galien Forum Africa	Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2021	Macky Sall	Republic of Senegal	President	Galien Forum Africa	Inaugural Panel
2021	Amadou Alpha Sall	Pasteur Institute - Dakar	Director	Galien Forum Africa	Innovations & ethic for global health security
2020	Galaye Sall	Country Coordinating Mechanism of the CCM Global Fund (Senegal)	President	Galien Forum Africa	Financing the response to covid 19
2020	Amadou Alpha Sall	Pasteur Institute - Dakar	Director	Galien Forum Africa	Screening strategies for a person suspected of covid 19: state of play, strengths, points for improvement & recommendations. sub-theme 2:
2018	Amadou Alpha Sall	Pasteur Institute - Dakar	Director	Galien Forum Africa	Remarkable women engage for humanity
2018	Amadou Alpha Sall	Pasteur Institute - Dakar	Director	Galien Forum Africa	managing infectious diseases & pandemics
2019	Bengt Samuelsson	Former President, Karolinska Institute; Former Chairman, Nobel Foundation	Nobel Laureate;	Galien Forum USA	The marriage of technology & medicine: bringing out the best in each other
2017	Bengt Samuelsson	Karolinska institute & Former chairman of the Nobel Foundation	Nobel Laureate, Former President	Galien Forum USA	Atrial fibrillation
2016	Bengt Samuelsson	Karolinska Institute & Former chairman of the Nobel Foundation	Nobel Laureate, Former President	Galien Forum USA	Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2015	Bengt Samuelsson	Karolinska Institute & Former Chairman of the Nobel Foundation. Stockholm, Sweden	Nobel Laureate, Former President	Galien Forum USA	Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2014	Bengt Samuelsson	Karolinska institute & Former chairman of the Nobel Foundation	Nobel Laureate, Former President	Galien Forum USA	A new agenda for global health
2011	Bengt Samuelsson	Karolinska institute & Former chairman of the Nobel Foundation	Nobel Laureate, Former President	Galien Forum USA	How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2010	Bengt Samuelsson	Karolinska institute & Former chairman of the Nobel Foundation	Nobel Laureate, Former President	Galien Forum USA	The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2019	Alfred Sandrock	Biogen	Executive Vice-President & Chief Medical Officer	Galien Forum USA	Spinal muscular atrophy: charting the pathway to clinical progress
2020	Rokia Sanogo	National Institute of Public Health of Mali, WHO	Head of the traditional medicine & Vice-president of the Advisory Committee on Traditional Medicine	Galien Forum Africa	Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5:
2015	Luca Santarelli	Roche Pharma Research & Early Development, Roche	Former Senior Vice President, Head of Neuroscience, Ophthalmology & Rare Diseases (NORD),	Galien Forum USA	Autism - the next decade
2021	Oulimata Sarr	(West & Central Africa) International – Senegal	UN Women Dakar Regional Director	Galien Forum Africa	Socio-economic consequences, equity & gender in the global health security
2020	Oulimata Sarr	UN Women	Regional Director	Galien Forum Africa	Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2020	Fatou Sarr Sow	Gender Laboratory (Senegal)	Director	Galien Forum Africa	Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2012	Nadeem Sarwar	Pfizer	Senior Director - Head, Population Research & Head,Cardiovascular Genetics,	Galien Forum USA	Addressing big datachallenges in genomics & personalized healthcare
2020	George Scangos	Vir Biotechnology	Chief Executive Officer	Galien Forum USA	The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2014	George A. Scangos	Biogen Idec	Chief Executive Officer	Galien Forum USA	Us health reform
2022	Tom Schall	ChemoCentryx	President, CEO, Director	Galien Week of Innovation	BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021	Adam Schayowitz	Pfizer Oncology	Medicine Team Group Lead (Breast Cancer, Colorectal Cancer & Melanoma)	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2019	David Schenkein	Agios Pharmaceuticals	General Partner, GV; Executive Chairman of the Board & Former Chief Executive Officer,	Galien Forum USA	Can disruptive innovation positively impact healthcare costs?
2018	David Schenkein	Agios Pharmaceuticals	Chief Executive Officer	Galien Forum USA	Cancer in a time of disruption
2019	Leonard S. Schleifer	Regeneron Pharmaceuticals	Founder, President & Chief Executive Officer,	Galien Forum USA	Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2013	Leonard S. Schleifer	Regeneron	Founder, President & Chief Executive Officer,	Galien Forum USA	Affordable care act us healthcare in transition: the stakes for industry
2020	Douglas Schlichting	Eli Lilly & Company	Development Director Immunology Product Development – baricitinib rheumatoid arthritis & COVID-19	Galien Week of innovation	The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2014	Corinne Schmitz	Blue-Reg pharma Consult	President	Galien Foum Monaco	Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2016	Jim Scholefield	Merck & Co., Inc.	Executive Vice President, Chief Information & Digital Officer	Galien Forum USA	Delivering on the patient promise of gene therapy
2020	Rob Scott	Abbvie	Retired Chief Medical Officer	Jerusalem Ethics Forum	Tracking bioethics: transparency, trust & the industry’s social imperatives
2020	Jessica S. Scott	Takeda Pharmaceuticals	Head of R&D Patient Engagement Office	Jerusalem Ethics Forum	Tracking bioethics: transparency, trust & the industry’s social imperatives
2022	Rob Scott,	Alcon	Vice President, Intraocular Devices R&D	Galien Week of Innovation	Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2020	Theodore F. Search	Skipta	Chief Executive Officer	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2020	Theodore F. Search	Skipta	Chief Executive Officer	Galien Week of innovation	Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2021	Penda Seck	Committee to Combat Violence against Women (CLVF) Senegal	President	Galien Forum Africa	Socio-economic consequences, equity & gender in the global health security
2020	Annette Seck Ndiaye	PNA Senegal	Director	Galien Forum Africa	Covid 19 drug supply chain in africa: challenges & perspectives
2020	Sandi See Tai	Pfizer Global Product Development Pfizer Inc.	Vice President, Medicine Team Lead for Amyloid, Rare Neuro & Cardiac	Galien Week of innovation	The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2021	Amal El Fallah Seghrouchni	Sorbone Universiti	Intelegence Articielle	Galien Webinars Series	The impact of digital technology in clinical trials: ethical considerations (french edition)
2020	Adam Selamani	Luxembourg	Health Digital expert	Galien Forum Africa	What place for digital health & innovations? sub-theme 3:
2012	Dennis Selkoe	Harvard Medical School; Center for Neurologic Diseases, Brigham & Women's Hospital,& Vincent & Stella Coates Professor of Neurologic Diseases,	Co-Director	Galien Forum USA	Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2016	Magnus Settergren	Karolinska Institutet & Karolinska University Hospital Stockholm	Associate Professor, Interventional Cardiologist,	Galien Forum USA	The marriage of technology & medicine: bringing out the best in each other
2020	Dan Sexton	Takeda Pharmaceutical Company Limited	Strategy Lead	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2020	Moussa Seydi	Clinic SMIT	Head of Department of Infectious & Tropical Diseases	Galien Forum Africa	Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3:
2021	Stephanie Seydoux	Global Health France	Ambassador	Galien Forum Africa	Socio-economic consequences, equity & gender in the global health security
2020	Gaurav Shah	Rocket Pharmaceuticals, Inc	President & Chief Executive Officer	Galien Forum USA	The promise of gene therapy
2021	Javad Shahidi	Daiichi Sankyo	Vice President, Global Oncology R&D	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2020	Javad Shahidi	Daiichi Sankyo	Vice President, Global Oncology R&D	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2021	Narinder S. Shargill	Global Medical Affairs	Vice President	Galien Week of innovation	What is med tech innovation doing for patients with specialized needs for treatment?
2016	Jonathan Sheldon	Oracle	Global Vice President, Healthcare, Health Sciences Global Business Unit,	Galien Forum USA	Precision medicine: delivering on the promise
2015	Jonathan Sheldon	Oracle Health Sciences	Global Vice President,	Galien Forum USA	Us health reform: partnering, pricing & politics
2014	Jonathan Sheldon	Oracle Health Sciences	Global Vice President,	Galien Forum USA	The brain initiative
2013	Jonathan Sheldon	Oracle Health Sciences	Global Senior Director of Translational Medicine,	Galien Forum USA	Personalized medicine: effect on drug r&d & patient care
2013	Morgan Sheng	Genentech	Vice President, Neuroscience,	Galien Forum USA	Neurodegenerative disease drug progress
2021	Michel Sidibe	African Medicines Agency AMA-UA International – Mali	African Union Special Envoy	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020	Michel Sidibe	Mali	Former Minister of Health	Galien Forum Africa	Health break
2018	Michel Sidibe	UNAIDS	Chief Executive Officer	Galien Forum Africa	Financing africa’s healthcare
2013	Elliott Sigal	Bristol Myers Squibb	Former Executive Vice President, Chief Scientific Officer & President, R&D	Galien Forum USA	Improving efficiency in drug development
2022	Cynthia Silva	Outset Medical, Inc.	Clinical Affairs Outset Medical	Galien Week of Innovation	Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2011	Jonathan Silverstein	OrbiMed Advisors	Partner	Galien Forum USA	Funding innovation new trends in the healthcare m&a l& scape
2010	Jonathan Silverstein	OrbiMed Advisors	Partner	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2020	Ute Simon	AAA ( a Novartis company)	Head Global Medical Affairs	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2019	Nancy Simonian	Syros Pharmaceuticals	President & Chief Executive Officer	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2021	Peter Singer	WHO DG International – Canada	Special Advisor	Galien Forum Africa	Innovations & ethic for global health security
2020	Laksen Sirimanne	Edwards Lifesciences	Vice President, Research & Development	Galien Week of innovation	How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2022	Laksen Sirimanne	Edwards Lifesciences	R&D Transc Heart Valve	Galien Week of Innovation	Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2019	Daniel M. Skovronsky	Eli Lilly Research Laboratories & Company	President & Chief Scientific & Medical Officer,	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2015	Laura Slatkin	New York Collaborates for Autism	Co-Founder	Galien Forum USA	Autism - the next decade
2020	Martha Smit	Private Pharmaceutical Sector South Africa	Life Sciences, Africa	Galien Forum Africa	Place of local production in the pharmaceutical sector sub-theme 4:
2018	Martha Smit	Life Sciences Practice group, Johannesburg	Partner, Fasken; Member	Galien Forum Africa	Universal access to essential & others medicines
2019	Robin Smith	STEM for Life Foundation, USA	Founder	Jerusalem Ethics Forum	Ethical considerations around patient choice & human enhancement in healthcare?
2019	Robin Smith	STEM for Life Foundation, USA	Founder	Jerusalem Ethics Forum	“artificial intelligence & ethics”
2015	Robin L. Smith	Neostem & Cura Foundation	Founder	Galien Forum USA	Fireside chat \| delivering on the patient promise of gene therapy
2022	Kimberly Smith	ViiV Healthcare	Sr VP Head of R&D	Galien Week of Innovation	Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2021	Kim Smith-Whitley	GBT	Executive Vice President & Head of Research & Development	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2022	Michael Sneed	Johnson & Johnson	Executive Vice President, Global Corporate Affairs & Chief Communication Officer	Galien Webinars Series	Golden Jubilee - Best BioTech Category
2020	Cheikh Sokhna	Research Institute for Development (Senegal)	Director of Research	Galien Forum Africa	Clinical trials in africa sub-theme 2:
2021	Apolline Sondo	DITD of the University Hospital – Burkina Faso	Head of the department of infectious & tropical diseases	Galien Forum Africa	Involvement of women researchers in the mhw
2020	Apolline Sondo	Ouagadougou (Burkina Faso)	Head of the Infectious & Tropical Diseases Department SMIT	Galien Forum Africa	Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3:
2021	Vera Songwe	UN Economic Commission for Africa International – Cameroon	Executive Secretary	Galien Forum Africa	Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2022	Harpreet Sood	Huma	VP, Primary Care & Clinical Partnerships - Moderator	Galien Week of Innovation	Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2021	Yaye Sophietou Diop	Speak Up Africa – Senegal	Advocacy Specialist	Galien Forum Africa	The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2011	Pascal Soriot	AstraZeneca	Chief Executive Officer	Galien Forum USA	Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2020	Jonathan Sorof	Global Blood Therapeutics	Senior Vice President, Head of Medical Affairs	Galien Week of innovation	Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2020	Lukas K. S Sosoe	University of Luxembourg	Teacher	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2021	Quentin Soulet De Brugiere	Dreem	Co-Founder & Chief Executive Officer	Galien Week of innovation	Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2020	Mohamed Soumah	Organ Transplantation & Donation Commission (Senegal)	Head of the Department of Forensic Medicine & member	Galien Forum Africa	Current situation of the response, challenges & prospects.sub-theme 1:
2021	Khoudia Sow	UCAD Senegal	President	Galien Forum Africa	Socio-economic consequences, equity & gender in the global health security
2021	Samba Sow	Vaccine Development Center (CVD), Minister of Health, Mali	Director General	Galien Forum Africa	Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020	Papa Salif Sow	Program Development & Management, Access Operations & Emerging Markets, Africa / Geneva. GILEAD sciences	Vice President	Galien Forum Africa	Vaccine production: state of play & perspectives sub-theme 4
2020	Mouhamadou Sow	Teranga Pharma «Ensuring the pharmaceutical sovereignty of Senegal»	Managing Director	Galien Forum Africa	Place of local production in the pharmaceutical sector sub-theme 4:
2020	Jeffrey Spaeder	IQVIA	Chief Medical & Scientific Officer & Senior Vice President	Galien Forum USA	The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2019	Jeffrey Spaeder	IQVIA	Chief Medical & Scientific Officer & Senior Vice President	Galien Forum USA	What’s holding back the technology revolution in clinical trials?
2013	Reisa Sperling	Harvard Medical School Department of Neurology, Brigham & Women’s Hospital	Neurology	Galien Forum USA	Neurodegenerative disease drug progress
2020	Sam Spigelman	Janssen Research & Development, LLC	Senior Global Medical Affairs Leader	Galien Week of innovation	What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2022	Sanjay Srivastava	Accenture	Managing Director LifeSciences Moderator	Galien Week of Innovation	Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2021	Nagaraja Srivatsan	IQVIA	Senior Vice President & Chief Digital Officer, R&DS Technology Solutions	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-22
2021	Nagaraja Srivatsan	IQVIA	Senior Vice President & Chief Digital Officer, R&DS Technology Solutions	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 6
2021	Nagaraja Srivatsan	IQVIA	Senior Vice President & Chief Digital Officer, R&DS Technology Solutions	Galien Week of innovation	Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2022	Neil Stahl	Regeneron	EVP, Research and Development	Galien Week of Innovation	Laureates Media Presentation
2014	Jay Stamatis	AbbVie	Vice President, Corporate Strategy Office; Head of Business Development & Acquisitions,	Galien Forum USA	Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2015	Glenn D. Steele Jr.	Geisinger Health System	Chairman, xG Health Solutions; Former Chief Executive Officer	Galien Forum USA	Us health reform: partnering, pricing & politics
2015	Glenn D. Steele Jr.	Geisinger Health System	Chairman, xG Health Solutions; Former Chief Executive Officer	Galien Forum USA	Delivering on the patient promise of gene therapy
2014	Steven H. Stein	Novartis Oncology US	Senior Vice President, US Clinical Development & Medical Affairs,	Galien Forum USA	Cancer immunotherapeutics
2021	Sally Stephens	Medicines360	Corporate Strategy, Business Development, Marketing/Sales, & the Developing Countries Program	Galien Week of innovation	Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions?
2012	Scot Stevens	UPMC CancerCenter & UPCI,Director Personalized Medicine Technology,	Chief Information Officer	Galien Forum USA	Addressing big datachallenges in genomics & personalized healthcare
2020	Paul Stoffels	Johnson & Johnson	Vice Chairman of the Executive Committee & Chief Scientific Officer -	Galien Forum USA	Covid-19 vaccines: the path to the holy grail
2022	Jayme Strauss	Viz.ai	Chief Clinical Officer	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2012	Eliane Strosberg	Art & Science - Belgium	Professor	Galien Forum USA	Art & science: from anatomy to genetics
2015	Lorenz Studer	The Center for Stem Cell Biology Developmental Biology Program, The Memorial Sloan-Kettering Cancer Center	Director	Galien Forum USA	Untangling the web of neurodegeneration: how far & how soon?
2021	Harrison Suhnfor	H&S Technologies – Cameroun	Young Innovators	Galien Forum Africa	Meeting of young innovators with investors
2021	Mark Sullivan	Medicines Development for Global Health	Founder & Managing Director	Galien Week of innovation	With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2020	Mark Sullivan	Medicines Development for Global Health	Founder & Managing Director	Galien Week of innovation	Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2012	Anthony Sun	Aisling Capital	Partner	Galien Forum USA	The changing face of chinese healthcare
2022	Sally Sussman	Pfizer	Chief Corporate Affairs Officer, Executive Vice President	Galien Webinars Series	Golden Jubilee - Best Vaccine Category
2020	Soumya Swaminathan	World Health Organization	Chief Scientist	Jerusalem Ethics Forum	Societal, legal & ethical challenges around access to covid-19 vaccines
2015	Julie Sweet	Accenture	Chief Executive Officer & Chair of the Board	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2020	Abdou Aziz Sy	Sabodala Gold	Managing Director	Galien Forum Africa	Impact of the covid 19 pandemic on the natural resources sector sub-theme 2:
2021	Cheikna Sylla	CODES & Honorary Director of the UFR of Health Sciences of Thies – Senegal	President	Galien Forum Africa	Conference on reform in health training
2011	Kevin Tabb	Stanford Hospital & Clinics	Chief Medical Officer	Galien Forum USA	Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2022	Ramita Tandon	Walgreens	Chief Clinical Trials Office	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2018	Hong Tang	Pasteur Institute of Shanghai	Director	Galien Forum Africa	Remarkable women engage for humanity
2018	Hong Tang	Pasteur Institute of Shanghai	Director	Galien Forum Africa	managing infectious diseases & pandemics
2021	Conrad Tankou	GIC Space	Chief Executive Officer	Galien Forum Africa	Leadership & innovation, meet the winners of the africa young innovators award for health
2010	Mary Tanner	Peter J. Solomon Company	Managing Director	Galien Forum USA	Biomedical innovation: funding challenges & developing public/private partnership incentives
2022	Marc Taub	Abbott	Divisional VP Technical Operations	Galien Week of Innovation	Laureates Media Presentation
2015	Marti Taylor	OneFifteen	President & Chief Executive Officer	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2020	Alain Tehindrazanarivelo	African Regional Expert Committee on Traditional Medicine (Madagascar)	Neurologist & member	Galien Forum Africa	Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5:
2021	Pamela Tenaerts	Medable, Inc	Chief Scientific Officer	Galien Week of innovation	How far are we from achieving the health system world of the connected patient?
2015	Marc Tessier-Lavigne	The Rockefeller University, New York,	President, Professor Laboratory of Brain Development & Repair	Galien Forum USA	Untangling the web of neurodegeneration: how far & how soon?
2015	Marc Tessier-Lavigne	The Rockefeller University, New York,	President, Professor Laboratory of Brain Development & Repair	Galien Forum USA	Delivering on the patient promise of gene therapy
2014	Marc Tessier-Lavigne	The Rockefeller University, New York,	President, Professor Laboratory of Brain Development & Repair	Galien Forum USA	Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2013	Marc Tessier-Lavigne	The Rockefeller University, New York,	President, Professor Laboratory of Brain Development & Repair	Galien Forum USA	Presentation of the pershing square sohn prize for young investigators in cancer research in new york city
2013	Marc Tessier-Lavigne	The Rockefeller University, New York,	President, Professor Laboratory of Brain Development & Repair	Galien Forum USA	Neurodegenerative disease drug progress
2021	Sanskriti Thakur	Medable	Chief Growth Officer	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021	Sanskriti Thakur	Medable	Chief Growth Officer	Jerusalem Ethics Forum	Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2022	Sans Thakur	Medable	Chief Growth Officer Moderator	Galien Week of Innovation	Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2018	Ibrahima Thiaw	Sahel	Special Advisor	Galien Forum Africa	The health consequences of climate change
2018	Mame Thierno Dieng	Senegal	Minister of the Environment	Galien Forum Africa	The health consequences of climate change
2012	William Thies	Alzheimer's Association	Chief Medical & Scientific Officer	Galien Forum USA	Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2021	Elizabeth H.Z. Thompson	Horizon	Research & Development	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2016	Craig Thompson	Memorial Sloan-Kettering Cancer Center ,	President & Chief Executive Officer	Galien Forum USA	Promise - & politics - in the fight against cancer
2020	Mads Krogsgaard Thomsen	Novo Nordisk A/S	Executive Vice President & Chief Scientific Officer	Galien Forum USA	The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2018	Madeleine Thomson	Wellcome Trust	Head of Climate Impacts	Galien Forum Africa	The health consequences of climate change
2011	Nancy Thornberry	Kallyop	Chief Executive Officer	Galien Forum USA	The gut microbiome: opportunities & challenges
2020	Ramon Tiu	Astellas Pharma Global Development Global Medical Leader, Gilteritinib Program	Executive Medical Director	Galien Week of innovation	Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2022	Jaya L. Tiwari	XVIVO Perfusion	Clinical & Regulatory Affairs	Galien Week of Innovation	Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2011	Eric Topol	Scripps Research Translational Institute, Author, Deep Learning	Executive Vice President & Chair of Innovative Medicine, Director & Founder	Galien Forum USA	The marriage of technology & medicine: bringing out the best in each other
2021	Emma Toure Cuq	URGOTech Inc.	Chief Scientific Officer	Galien Week of innovation	Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2021	Coumba Toure Kane	University of Sine Saloum – Senegal	IRESSEF, Chancellor	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 7
2014	Olivia Tournay Flatto	Pershing Square Sohn Cancer Research Alliance	Executive Director	Galien Forum USA	Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2015	Kevin J. Tracey	The Feinstein Institute for Medical Researc	President	Galien Forum USA	Bioengineering for better health: what future for targeted drug delivery?
2019	Tomasz Trafny	Vatican	Official of the Pontifical Council for Culture	Jerusalem Ethics Forum	Ethical considerations around patient choice & human enhancement in healthcare?
2019	Tomasz Trafny	Pontifical Council for Culture, Vatican	Head of Science & Faith Department	Jerusalem Ethics Forum	“artificial intelligence & ethics”
2022	Thomas Triomphe	Sanofi-Pasteur MSD	VP, Vaccines	Galien Webinars Series	Golden Jubilee - Best Vaccine Category
2014	Nathaniel Turner	Flatiron Health, Inc.	Co-Founder	Galien Forum USA	The future of digital health
2014	Stephen J. Ubl	PhRMA	President & Chief Executive Officer	Galien Forum USA	Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2021	Marie Chantal Umunyana	Women Innovators Incubator program	Participant	Galien Forum Africa	Women & stem in the global health security context
2021	J.P. Urbanski	Baylis Medical	Director of Strategic Marketing	Galien Week of innovation	How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2022	J.P. Urbanski	Boston Scientific \| Baylis Medical	Dir Strategic Mkg Cardiology Baylis	Galien Week of Innovation	Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2021	Juan Pablo Uribe	Global Financing Facility GFF International – Colombia	Director	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 8
2022	Giovanna Usvardi	Chiesi Group	Head of Global Communication & Public Affairs	Galien Webinars Series	Golden Jubilee - Best Orphan Rare Category
2014	Roy Vagelos	Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc	Chairman	Galien Forum USA	Us health reform
2013	Roy Vagelos	Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc	Chairman	Galien Forum USA	Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2013	Roy Vagelos	Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc	Chairman	Galien Forum USA	Intro
2013	Roy Vagelos	Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc	Chairman	Galien Forum USA	Affordable care act us healthcare in transition: the stakes for industry
2012	Roy Vagelos	Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc	Chairman	Galien Forum USA	Welcome
2012	Roy Vagelos	Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc	Chairman	Galien Forum USA	Panel: “looking back, moving forward”
2022	Patrick Vallance	Government	Government Chief Scientific Adviser	Galien Forum UK	Access to innovation: optimizing health for patient populations
2022	Jérôme Van Biervliet	VIB	Managing Director	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2022	Filip Van den Wyngaert	Sanofi	MSc Global Head TTP	Galien Week of Innovation	BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2022	Lisette Van Gemert	University of Twente.	Professor	Galien Forum Netherlands	#VALUE!
2022	Roderick Van Grieken	The Netherlands Debate Institute	Founder & Director	Galien Forum Netherlands	#VALUE!
2020	Katherine Vandebelt	Oracle Health Science	Global Vice President, Clinical Innovation	Galien Week of innovation	The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2022	Ashkan Vaziri	BioSensics	Founder, CEO	Galien Week of Innovation	Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021	Rajeev Venkayya	Takeda Pharmaceuticals Ltd.	President, Global Vaccines Unit	Jerusalem Ethics Forum	Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2013	Rajeev Venkayya	Takeda Pharmaceuticals Ltd.	President, Global Vaccines Unit	Galien Forum USA	Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2021	Michele Verschoore	L’Oreal Research & Innovation (France)	Medical Director	Galien Forum Africa	Involvement of women researchers in the mhw
2019	Michele Verschoore	L’Oreal Research & Innovation (France)	Medical Director	Jerusalem Ethics Forum	Personalized genomics medicine: the value of knowing
2016	Philip Vickers	Shire plc	Global Head, Research & Development	Galien Forum USA	Precision medicine: delivering on the promise
2014	Christopher A. Viehbacher	Sanofi & Chairman Genzyme	Chief Executive Officer	Galien Forum USA	Us health reform
2022	Pam Vig	Mirum Pharmaceuticals, Inc.	Head of R&D	Galien Week of Innovation	Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2022	Michael Vincent	Pfizer Inc.	SVP CSO In & Immuno	Galien Week of Innovation	Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2013	Bert Vogelstein	Johns Hopkins School of Medicine	Professor of Oncology	Galien Forum USA	Keynote Personalized medicine: effect on drug r&d & patient care
2019	Andrew C. Von Eschenbach	Samaritan Health Initiatives, Inc., USA	President	Jerusalem Ethics Forum	Health policy & financing innovation: ethical considerations, cost & the role of the patient
2019	Andrew C. Von Eschenbach	Samaritan Health Initiatives, Inc., USA	President	Jerusalem Ethics Forum	Dominion over all of creation: progress & responsibility
2019	Andrew C. Von Eschenbach	Samaritan Health Initiatives, Inc., USA	President	Jerusalem Ethics Forum	2020/2030 agenda “facing the next ethical challenges”
2014	Robert H. Vonderheide	Perelman School of Medicine, University of Pennsylvania	Hanna Wise Professor of Cancer Research ,	Galien Forum USA	Cancer immunotherapeutics
2019	Michel Vounatsos	Biogen inc	Chief Executive Officer & Director	Galien Forum USA	The gut microbiome: opportunities & challenges
2015	Michel Vounatsos	Biogen	Chief Executive Officer	Galien Forum USA	Delivering on the patient promise of gene therapy
2018	Salimata Wade	University Cheikh Anta Diop - Senegal	Nutritionist	Galien Forum Africa	Addressing chronic malnutrition
2022	Mel Walker	MW Consulting	Biotech/Digital Health Adviser	Galien Forum UK	Access to innovation: optimizing health for patient populations
2022	Mark Walport	Imperial College, London UK	Honorary Distinguished Professor of Medicine	Galien Forum UK	Welcome Remarks
2014	Sihong Wang	City University of New York City College	Prize Winner & Associate Professor of Biomedical Engineering,	Galien Forum USA	Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2021	Rhoda Wanyenze	School of Public Health & College of Health Sciences, Makerere University – Uganda	Dean	Galien Forum Africa	Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 9
2020	Majesty Ihou Wateba	Health Sciences of the University of Lome (Togo)	Minister of Health & Dean of the Faculty	Galien Forum Africa	Socio-economic impact of the covid 19 pandemic sub-theme 5
2017	Ryan Watts	Denali Therapeutics	Co-founder, President & Chief Executive Officer	Galien Forum USA	Addressing unmet medical needs with early-stage life science venture capital
2015	Ryan Watts	Denali Therapeutics	Co-founder, President & Chief Executive Officer	Galien Forum USA	Untangling the web of neurodegeneration: how far & how soon?
2021	Scott C. Weaver	University of Texas Medical Branch	John Sealy Distinguished University Chair in Human Infections & Immunity Chair, Department of Microbiology & Immunology Director, Institute for Human Infections & Immunity; & Scientific Director Galveston National Laboratory GVN Center Director	Jerusalem Ethics Forum	Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2021	Iain Webb	Bayer	Head of US Medical Affairs Oncology	Galien Week of innovation	Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2021	Iain Webb	Bayer	Head of US Medical Affairs Oncology	Galien Week of innovation	What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2015	Christophe Weber	Takeda Pharmaceutical Company Limited	PharmD, Representative Director, President & Chief Executive Officer,	Galien Forum USA	How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2022	Michelle Weese	Bristol-Myers Squibb	EVP, Corporate Affairs	Galien Webinars Series	Golden Jubilee - Best BioTech Category
2020	Tal Wenderow	VOCALIS HEALTH	Chief Executive Officer	Galien Webinars Series	The digital health enterprise: start-up trends & the culture of big pharma
2011	Robert M. Wenham	Moffitt Cancer Center	Principal Investigator, Total Cancer Care Programs of Gynecologic Oncology & Experimental Therapeutics	Galien Forum USA	The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2019	Steve Whitehead	NIH National Institute for Allergies & Infectious Diseases	Senior Associate Scientist, Laboratory of Infectious Diseases,	Galien Forum USA	Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2018	Marion Wiesel	The Elie Wiesel Foundation for Humanity New York	Chair	Galien Forum Africa	Remarkable women engage for humanity
2012	Elie Wiesel	Author & Peace Nobel Prize Laureate	Professor	Galien Forum USA	Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2022	Roy Wiesner	aMoon Fund	Managing Director	Galien Week of Innovation	Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020	Roy Wiesner	aMoon	Managing Director	Galien Webinars Series	The digital health enterprise: start-up trends & the culture of big pharma
2022	Chris Williams	Sanofi	Head of Corporate Communications & Brand	Galien Webinars Series	Golden Jubilee - Best Pharmaceutical Category
2021	Alisa Wilson	Accenture	Managing Director, Life Sciences	Galien Week of innovation	Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2011	Ron Winslow	WSJ	Senior Medical & Health Care Writer	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2021	Pascale Witz	Sanofi et PDG de GE Pharmaceutical Diagnostic	Founder & CEO	Galien Webinars Series	The impact of digital technology in clinical trials: ethical considerations (french edition)
2015	Amanda Woerman	Institute for Neurodegenerative Diseases, (UCSF)	Assistant Professor of Neurology	Galien Forum USA	Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020	Cen Xu	Amgen Neuroscience	Executive Director	Galien Week of innovation	Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2022	George Yancopoulos	Regeneron	Co-Founder, president and chief scientific officer	Galien Forum USA	CEO Panel
2020	George Yancopoulos	Regeneron Pharmaceuticals	President & Chief Scientific Officer -	Galien Forum USA	Immunology from both sides: oncology & autoimmune disease
2017	George Yancopoulos	Regeneron Pharmaceuticals	President, & Chief Scientific Officer,	Galien Forum USA	Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2021	Nadim Yared	CVRx	President & Chief Executive Officer	Galien Week of innovation	How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2018	Yazdan Yazdanpanah	Inserm	Professor	Galien Forum Africa	managing infectious diseases & pandemics
2018	Yazdan Yazdanpanah	Inserm	Professor	Galien Forum Africa	Remarkable women engage for humanity
2021	Ashley Yegin	Takeda	Global Medical Unit Head, Rare Disease/HAE	Galien Week of innovation	Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2014	Krishna Yeshwant	Google Ventures	General Partner	Galien Forum USA	The future of digital health
2021	Tal Zaks	Moderna	Chief Medical Officer	Galien Webinars Series	The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-23
2022	Nafeez Zawahir	Publicis	Chief Medical Officer - Moderator	Galien Week of Innovation	Laureates Media Presentation
2011	Jide Zeitlan	Keffi Group	Chief Executive Officer	Galien Forum USA	Funding innovation new trends in the healthcare m&a l& scape
2014	Elias Zerhouni	Sanofi	President, Global R&D.	Galien Forum USA	A new agenda for global health
2015	Feng Zhang	Massachusetts Institute of Technology	Professor	Galien Forum USA	Delivering on the patient promise of gene therapy
2021	Eyal Zimlichman	ARC Innovation Program	Founder & Director	Galien Webinars Series	The incubators of innovation: academic medical centers as digital health champions
2016	Bernard Zinman	Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Sinai Centre for Diabetes. Mount Sinai Hospital, Toronto, Ontario	Senior Scientist Director of the Leadership	Galien Forum USA	Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2013	Huda Zoghbi	Baylor College of Medicine	Professor	Galien Forum USA	Personalized medicine: effect on drug r&d & patient care
2022	Lynne Zydowsky	Alexandria summit; chief of science, Alexandria real estate equities, inc./Alexandria venture investments	Chief Science Officer	Galien Forum USA	Mental health in America, a public health crisis
2021	Lynne Zydowsky	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments	Chief Science Officer	Galien Forum USA	Combating the opioid crisis in america
2020	Lynne Zydowsky	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Chief Science Officer	Galien Forum USA	Covid-19 vaccines: the path to the holy grail
2018	Lynne Zydowsky	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Chief Science Officer	Galien Forum USA	Cancer in a time of disruption
2017	Lynne Zydowsky	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Chief Science Officer	Galien Forum USA	Addressing unmet medical needs with early-stage life science venture capital
2014	Lynne Zydowsky	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Chief Science Officer	Galien Forum USA	The future of digital health
2011	Lynne Zydowsky	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit	Chief Science Officer	Galien Forum USA	A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2014	Thierry Zylberberg	Orange Healthcare	Executive Vice President	Galien Foum Monaco	Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2023	Jane Adam	St. Georgeâ€™s NHS Trust	NICE Technology Appraisal Committee and Consultant,	Galien Forum UK	What is the role of the NHS in public sector innovation?
2023	Lucy Chappell	Department of Health & Social Care (DHSC)	Chief Scientific Adviser	Galien Forum UK	What is the role of the NHS in public sector innovation?
2023	Ara Darzi of Denham	Imperial College London	Co-Director, Institute of Global Health Innovation,	Galien Forum UK	impact of AI / Digital on healthcare
2023	Luisa Freitas Dos Santos	GSK	Vice President - Global Clinical Supply Chain,	Galien Forum UK	Driving resilience in global medical supply chains
2023	Will Gibbs	Octopus Ventures	Healthtech Partner,	Galien Forum UK	impact of AI / Digital on healthcare
2023	Alison Holland	Medable	Executive GM, Digital and Decentralized Solutions,	Galien Forum UK	impact of AI / Digital on healthcare
2023	Sarah Justine Kerruish	Kheiron Medical Technologies	Chief Strategy Officer,	Galien Forum UK	impact of AI / Digital on healthcare
2023	Stephanie Kuku	World Health Organizationâ€™s Department of Digital Health and Innovation	Health Technology Director, Senior Consultant, Hardian Health & Senior Adviser and Consultant,	Galien Forum UK	impact of AI / Digital on healthcare
2023	Ravi Limaye	Wockhardt UK	CEO / Managing Director,	Galien Forum UK	Driving resilience in global medical supply chains
2023	Murray Lumpkin	Bill & Melinda Gates Foundation	Lead for Global Regulatory Systems Initiatives	Galien Forum UK	Access to innovation: exploring solutions to global challenges.
2023	Deusdedit Mubangizi	World Health Organization	Head of Prequalification Unit	Galien Forum UK	Access to innovation: exploring solutions to global challenges.
2023	Munir Pirmohamed	University of Liverpool	David Weatherall Chair of Medicine,	Galien Forum UK	Driving resilience in global medical supply chains
2023	Sam Roberts	National Institute for Health and Care Excellence	Chief Executive Officer	Galien Forum UK	Access to innovation: exploring solutions to global challenges.
2023	Roland Sinker	Cambridge University Hospitals NHS Foundation Trust	Chief Executive	Galien Forum UK	What is the role of the NHS in public sector innovation?
2023	Helen Stokes Lampard	Academy of Medical Royal Colleges	Chair	Galien Forum UK	What is the role of the NHS in public sector innovation?
2023	Steffen Thirstrup	European Medicines Agency	Chief Medical Officer	Galien Forum UK	Access to innovation: exploring solutions to global challenges.
2023	Per Troein	IQVIA	Vice President Strategic Partners,	Galien Forum UK	Driving resilience in global medical supply chains
2023	Mel Walker		Biotech/Digital Health Adviser	Galien Forum UK	Access to innovation: exploring solutions to global challenges.
2023	Bruce Warner	NHS	Deputy Chief Pharmaceutical Officer for England,	Galien Forum UK	Driving resilience in global medical supply chains
2023	Matthieu Leclerc-Chalvet	Therapixel	CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Rich Brancaccio	Revibe Technologies	Founder, Chief Innovation Officer	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	anam Shetty	Evolve Medical Systems	Founder, CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Rebecca Wilkins	Abbott - NeuroSphere Virtual Clinic	Divisional Vice President, Research & Development	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Sharief Taraman	Cognoa	CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Shailja Dixit	Curio	CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Eric Dessertenne	Biocorp	CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Alexander Riftine	IntelleWave	President, CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Mette Dyhrberg	Mymee	Founder, CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Eran Orr	XRHealth	CEO	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Ryan Brewster	NoviGuide	NoviGuide Clinical Consultant	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	MaryAnn Rizk	Rizk Management Advisors	CEO - Moderator	Galien Week of innovation	What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023	Chrissa McFarlane	Patientory, Inc	Founder, CEO	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Roy Cohen	Behavidence	CEO	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Eric Snyder	Hyperion	Director, Informatics / Technology Innovation	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Michelle Longmire	Medable	Co-Founder, CEO	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Darcy Forman	Science 37	Chief Delivery Officer	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Zahid Ali Ashraf	TECHMEDO	Founder, CEO	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Marisa Cruz	Empatica	Chief Medical Officer	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Joe DeVivo	Butterfly Network, Inc	President, Chairman, Chief Executive Officer	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Madeline Naylor	Skipta	CR, CTM - Moderator	Galien Week of innovation	Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023	Steven Lester, M.D.	Mayo Clinic and Arizona State University MedTech Accelerator	Founder, Chief Medical Officer	Galien Week of innovation	Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023	Gene D. Morse, PharmD	Center for Integrated Global Biomedical Sciences by University at Buffalo	Director, Center for Integrated Global Biomedical Sciences	Galien Week of innovation	Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023	Danina Kapetanovic	OROT CONNECTED HEALTH INCUBATOR BY CIUSSS WEST CENTRAL MONTREAL	Chief Innovation Officer	Galien Week of innovation	Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023	Konrad Dobschuetz	NHS Innovation Accelerator	National Director	Galien Week of innovation	Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023	Gil Bashe	FINN Partners	Managing Partner, Chair Global Health Purpose - Moderator	Galien Week of innovation	Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023	Isaac Middelmann	EIT Health Venture Centre of Excellence (VCoE)	Managing Director (ad interim)	Galien Week of innovation	An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023	Christopher Hentschel	Cube Labs	Chief Scientific Officer	Galien Week of innovation	An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023	Robert Karanja, PhD	Villgro Africa	Co-Founder	Galien Week of innovation	An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023	Mati Gill	AION Labs	CEO	Galien Week of innovation	An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023	Ron Cohen	Acorda Therapeutics	President, CEO - Moderator	Galien Week of innovation	An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023	Jim Lee	Incyte Corp.	Group Vice President, Head Inflammation and AutoImmunity	Galien Week of innovation	Gastrointestinal and adenocarcinoma cancers represent more than a quarter of all cancers. What are the epidemiological, cellular and molecular factors that are driving this trend, particularly among younger populations – and how is research science responding?
2023	Lamine Mbow	Boehringer Ingelheim	SVP, Global Head of Cancer Immunology BI - Moderator	Galien Week of innovation	Gastrointestinal and adenocarcinoma cancers represent more than a quarter of all cancers. What are the epidemiological, cellular and molecular factors that are driving this trend, particularly among younger populations – and how is research science responding?
2023	Patrice Lee	Pfizer Inc.	Vice President, Pharmacology, Toxicology and Exploratory Development	Galien Week of innovation	Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023	Susan Pandya	Servier Pharmaceuticals	Head of Cancer Metabolism Global Development Oncology & Immuno-Oncology	Galien Week of innovation	Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023	Robert Consalvo	H1	Senior Director of Strategic Commercial Engagement - Moderator	Galien Week of innovation	Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023	Josh Bauml	Janssen Pharmaceutical Companies of Johnson & Johnson	Global Medical Head Amivantamab NSCLC Program	Galien Week of innovation	Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023	Lewis Warrington, MD	Ironshore	Chief Medical Officer	Galien Week of innovation	CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success?
2023	Machelle Manuel, PhD	Amylyx Pharmaceuticals, Inc.	Vice President, Head Global Medical Affairs	Galien Week of innovation	CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success?
2023	Hugh Marston	Boehringer Ingelheim	Head of Global CNS Diseases - Moderator	Galien Week of innovation	CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success?
2023	Jessica Federer		Chief Digital Officer - Moderator	Galien Week of innovation	With a global pandemic raising awareness of the importance of vaccines and anti-viral medicines, are private-sector R&D incentives aligned to meet growing market needs? Gauging unmet needs in women’s health therapeutics and promising new trends in research.
2023	Jared Baeten	Gilead Sciences, Inc.	Vice President, Clinical Development, HIV Franchise Head	Galien Week of innovation	With a global pandemic raising awareness of the importance of vaccines and anti-viral medicines, are private-sector R&D incentives aligned to meet growing market needs? Gauging unmet needs in women’s health therapeutics and promising new trends in research.
2023	Francisco Leon	Sanofi	Chief Scientific Officer & Co-Founder, Provention Bio	Galien Week of innovation	Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023	Paulo Fontoura	Genentech	SVP and Global Head of Neuroscience and I2O	Galien Week of innovation	Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023	Mike Vincent	Pfizer Inc.	Senior Vice President, Chief Scientific Officer, Inflammation & Immunology (I&I)	Galien Week of innovation	Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023	Michael Ringel	Boston Consulting Group (BCG)	Managing Director, Senior Partner - Moderator	Galien Week of innovation	Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023	Bill Mezzanotte	CSL / uniQure	EVP, Head of Research and Development	Galien Week of innovation	Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023	Arup amanik	Boehringer Ingelheim	Corporate Vice President	Galien Week of innovation	Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023	Monica Kumar	Sanofi	Global Project Head	Galien Week of innovation	Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023	Bahija Jallal	Immunocore	CEO	Galien Week of innovation	Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023	Kevin Brubacher	Bionest Partners, Accenture	Managing Director - Moderator	Galien Week of innovation	Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023	Tonya Resutek	Olympus America Inc.	Executive Director for Respiratory Marketing	Galien Week of innovation	How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023	David Webster	Body Vision Medical	CEO	Galien Week of innovation	How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023	David Brachman	GT Medical Technologies, Inc.	Co-Founder and Chief Technology Officer	Galien Week of innovation	How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023	Madeline Naylor	Skipta	Wellness Care - Moderator	Galien Week of innovation	How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023	Jason Spees	Impulse Dynamics	CEO	Galien Week of innovation	What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023	Laksen Sirimanne	Edwards Lifesciences	Senior Vice President, THV Research and Development	Galien Week of innovation	What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023	Matt Thompson	ENDOLOGIX LLC	CEO, President	Galien Week of innovation	What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023	Anew Easton	Terumo Aortic	Senior Global Product Manager	Galien Week of innovation	What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023	Robert Consalvo	H1	Senior Director of Strategic Commercial Engagement - Moderator	Galien Week of innovation	What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023	Steven Eror	Solo-Dex, Inc.	Chief Executive Officer	Galien Week of innovation	What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023	Jennifer Sipple	Outset Medical, Inc.	Vice President, Marketing	Galien Week of innovation	What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023	Arthur Rascon	Valencia Technologies Corporation	Chief Executive Officer	Galien Week of innovation	What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023	Gil Bashe	FINN Partners	Managing Partner Chair Global Health Purpose	Galien Week of innovation	What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023	Megan O’Meara	Seagen Inc.	Senior Vice President, Head of Clinical Development	Galien Week of innovation	What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023	Michael Vasconcelles, M.D., PhD	ImmunoGen, Inc.	Exec VP, Research, Development, and Medical Affairs	Galien Week of innovation	What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023	Lusong Lu	BeiGene	SVP, External Innovation	Galien Week of innovation	What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023	Kailash Swarna	Accenture	Managing Director - Moderator	Galien Week of innovation	What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023	Jordan Schecter	The Janssen Pharmaceutical Companies of Johnson & Johnson and Legend Biotech USA Inc	Vice President for Cellular Therapy	Galien Week of innovation	What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023	Eric Richards, MS, MPH	Daiichi Sankyo & AstraZeneca	Senior Vice President, Head of Global Regulatory Affairs	Galien Week of innovation	What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023	Rachel Kobos, MD	The Janssen Pharmaceutical Companies of Johnson & Johnson	Vice President Oncology Research & Development	Galien Week of innovation	What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023	Nafeez Zawahir, MD	Razorfish Health	Chief Medical Officer - Moderator	Galien Week of innovation	In the aftermath of the Covid-19 pandemic, what is the state of the vaccine business model? Will climate change, urbanization and an aging population require more investments in fighting a growing incidence of infectious diseases?
2023	Alejana Gurtman	Pfizer Inc.	SVP, Vaccine Clinical Research and Development	Galien Week of innovation	In the aftermath of the Covid-19 pandemic, what is the state of the vaccine business model? Will climate change, urbanization and an aging population require more investments in fighting a growing incidence of infectious diseases?
2023	Jane Parnes	Amgen USA	Executive Medical Director	Galien Week of innovation	As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise?
2023	Amy Sehnert	Bristol Myers Squibb	Vice President, Head of Cardiomyopathy and Heart Failure Clinical Development	Galien Week of innovation	As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise?
2023	Amir Kalali	CNS Summit, Co-Chair Decentralized Trial Research Alliance	Chairman, Chief Curator - Moderator	Galien Week of innovation	As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise?
2023	Michael Rosenblatt, MD	Galien Forum	Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc.	Galien Forum USA	Challenges to Individual and Public Health
2023	Sue Desmond-Hellmann, MD, MPH	Galien Forum	Former Chief Executive Officer of the Bill & Melinda Gates Foundation. Co-Chair of the Galien Forum	Galien Forum USA	Challenges to Individual and Public Health
2023	John Maraganore, PhD	Alnylam Pharmaceuticals	Former and Founding CEO	Galien Forum USA	Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023	Sangeeta N. Bhatia, MD, PhD	Massachusetts Institute of Technology	John J. and Dorothy Wilson Professor; Electrical Engineering and Computer Science, Institute for Medical Engineering and Science, Massachusetts Institute of Technology	Galien Forum USA	Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023	Adam Koppel, MD, PhD	Bain Capital Life Sciences	Partner	Galien Forum USA	Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023	Mike Nally	Flagship Pioneering	Chief Executive Officer, Generate Biomedicines; CEO-Partner	Galien Forum USA	Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023	Daphne Zohar	PureTech Health	Founder & Chief Executive Officer, Member of the Board of Directors	Galien Forum USA	Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023	Jeffrey Shaman, PhD	Columbia University	Professor and Director of the Climate and Health Program	Galien Forum USA	Climate Change and Public Health
2023	Gwen W. Collman, PhD, FISEE	National Institutes of Health	Director, Office of Scientific Coordination, Planning and Evaluation; National Institute of Environmental Health Sciences	Galien Forum USA	Climate Change and Public Health
2023	Ruxana aghia Akli	The Janssen Pharmaceutical Companies of Johnson & Johnson	Global Head, Global Public Health R&D	Galien Forum USA	Climate Change and Public Health
2023	Jessica Fanzo	The Columbia Climate School	Professor of Climate; Director, Food for Humanity Initiative	Galien Forum USA	Climate Change and Public Health
2023	Andy Haines	London School of Hygiene & Tropical Medicine	Professor of Environmental Change and Public Health	Galien Forum USA	Climate Change and Public Health
2023	Joel S. Marcus	Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Co-Founder, Alexandria Summit; Board Director, Navy SEAL Foundation and National Medal of Honor Museum; Co-Founder, OneFifteen	Executive Chairman & Founder	Galien Forum USA	A National Imperative to Combat Mental Illness and Addiction
2023	Lynne Zydowsky, PhD	Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; President & Co-Founder, Alexandria Summit	Chief of Science	Galien Forum USA	A National Imperative to Combat Mental Illness and Addiction
2023	Robin King	The Navy Seal Foundation	CEO	Galien Forum USA	A National Imperative to Combat Mental Illness and Addiction
2023	Representative Seth Moulton	Massachusetts’ Sixth Congressional District; U.S. Marine Corps (Ret.)	Member of Congress	Galien Forum USA	A National Imperative to Combat Mental Illness and Addiction
2023	Representative Michael Waltz	Florida’s Sixth Congressional District; U.S. Army Green Beret (Ret.); National Guard (Ret.)	Member of Congress	Galien Forum USA	A National Imperative to Combat Mental Illness and Addiction
2023	Michael Rosenblatt, MD	Galien Forum	Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc.	Galien Forum USA	Exclusive fireside chat featuring Alex Gorsky, former Chairman& CEO, Johnson & Johnso
2023	Alex Gorsky	Johnson & Johnson	Former Chairman and CEO	Galien Forum USA	Exclusive fireside chat featuring Alex Gorsky, former Chairman& CEO, Johnson & Johnso
2023	Bernard Poussot	Roche Holding & Cargill Inc. Former Chairman & CEO, Wyeth; Prix Galien Committee Chair (Categories: Medtech, Digital Health, IAE and StartUp)	Board Member	Galien Forum USA	Prix Galien Awards Ceremony - Categories: Best Medical Technology, Best Digital Health Solution, Best Incubator/Accelerator/Equity and Best StartUp
2023	Mikael Dolsten	Pfizer Research and Development	Chief Scientific Officer & President	Galien Forum USA	Obesity Science & Treatment Breakthroughs
2023	Stephen L. Gough	Novo Nordisk	Global Chief Medical Officer and Senior Vice President of Global Medical Affairs	Galien Forum USA	Obesity Science & Treatment Breakthroughs
2023	Lee M. Kaplan, MD, PhD	Geisel School of Medicine at Dartmouth	Professor of Medicine and Chief of the Section on Obesity Medicine	Galien Forum USA	Obesity Science & Treatment Breakthroughs
2023	Joe Nadglowski	Obesity Action Coalition	President & CEO	Galien Forum USA	Obesity Science & Treatment Breakthroughs
2023	Daniel M. Skovronsky, MD, PhD	Eli Lilly and Company	Executive Vice President, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories	Galien Forum USA	Obesity Science & Treatment Breakthroughs
2023	Søren Tullin	Boehringer Ingelheim	Senior Vice President & Global Head of Cardio Metabolic Disease Research	Galien Forum USA	Obesity Science & Treatment Breakthroughs
2023	James J. Collins	Broad Institute of MIT and Harvard	Termeer Professor of Medical Engineering & Science Professor	Galien Forum USA	AI’s Impact on Personal — and Public Health, Now & in the Future
2023	Regina Barzilay	MIT	School of Engineering Distinguished Professor for AI and Health	Galien Forum USA	AI’s Impact on Personal — and Public Health, Now & in the Future
2023	Eric Horvitz	Microsoft	Chief Scientific Officer	Galien Forum USA	AI’s Impact on Personal — and Public Health, Now & in the Future
2023	Ariel Katz	H1	CEO & Co-founder	Galien Forum USA	AI’s Impact on Personal — and Public Health, Now & in the Future
2023	Steve Quake	Chan Zuckerberg Initiative	Head of Science	Galien Forum USA	AI’s Impact on Personal — and Public Health, Now & in the Future
2023	Lieven Van der Veken	McKinsey & Company	Senior Partner	Galien Forum USA	AI’s Impact on Personal — and Public Health, Now & in the Future
2023	Petra Jantzer, PhD	Accenture	Senior Managing Director, Global Life Sciences Lead	Galien Forum USA	Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023	Michael Rosenblatt, MD	Galien Forum	Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc.	Galien Forum USA	Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023	Albert Bourla	Pfizer	Chairman & CEO	Galien Forum USA	Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023	Michael J. Dowling	Northwell Health	President & CEO	Galien Forum USA	Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023	David R. Epstein	Seagen	CEO	Galien Forum USA	Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023	David A. Ricks	Eli Lilly and Company	Chair & CEO	Galien Forum USA	Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2021	Robert Bradway	Amgen	Chairman & Chief Executive Officer	Galien Forum USA	CEO Session
2024	Michael Rosenblatt	Galien Forum	MD, Prix Galien Awards Committee Chair	Galien Webinars Series	Biotech, Pharma, Rare/Orphan Diseases
2024	Amy Sehnert	Bristol Myers Squibb	VP, Global Program Lead	Galien Webinars Series	Biotech, Pharma, Rare/Orphan Diseases
2024	Ruth Gimeno	Eli Lilly and Company	Group VP Diabetes & Metabolic Research	Galien Webinars Series	Biotech, Pharma, Rare/Orphan Diseases
2024	Stephen Gough	Novo Nordisk	Global Chief Medical Officer, SVP	Galien Webinars Series	Biotech, Pharma, Rare/Orphan Diseases
2024	Janine Lamar	Boehringer Ingelheim	Global Spesolimab Lead	Galien Webinars Series	Biotech, Pharma, Rare/Orphan Diseases
2024	Paul Monahan	CSL Behring	Executive Director, Senior Clinical Fellow, R&D, Hematology	Galien Webinars Series	Biotech, Pharma, Rare/Orphan Diseases
2024	Matt Kapusta	UniQure	CEO	Galien Webinars Series	Biotech, Pharma, Rare/Orphan Diseases
2024	Bernard Poussot	The Galien Foundation	Prix Galien Committee Chair	Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Michelle Longmire	Medable	Co-Founder and CEO	Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Robert Karanja	Villgro Africa	Co-Founder, Chief Innovation Office	Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Representative	Guardant Health		Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Lamine Mbow	Boehringer Ingelheim	PhD	Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Oded Kraft	GrayMatters Health	Co-Founder & CEO	Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Representative	Tessera Therapeutics		Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Representative	Volta Medical		Galien Webinars Series	Digital Health, Medtech, Accelerator/Incubator/Equity, Startup
2024	Shri Anil KHANNA	Modi Prix Galien India	Galien Forum Coordinator - Modi Prix Galien India Committee Member. Sr. Vice President, GM Modi Science Foundation, New Delhi	Modi Prix Galien India	Welcome remarks
2024	Professor Manju SHARMA	Modi Prix Galien India	Modi Prix Galien India Committee Chair Former Secretary to the Govt. of India, Department of Biotechnology. Chair New Initiative, NASI, Allahabad	Modi Prix Galien India	Opening remarks
2024	Dr Saurabh JAIN	Indegene	Vice President	Modi Prix Galien India	Scaling up genAI in life sciences: from pilots to production
2024	Sridhar ANJANAPPA	Infusion Systems Software R&D, Baxter Innovations and Business Solutions Pvt. Ltd	Sr. Manager	Modi Prix Galien India	Scaling up genAI in life sciences: from pilots to production
2024	Anirudh RANGANATHAN	Sekkei Bio	Co-founder	Modi Prix Galien India	Scaling up genAI in life sciences: from pilots to production
2024	Suresh SUBRAMANIAN	EY India	Partner and Life Sciences Leader	Modi Prix Galien India	Scaling up genAI in life sciences: from pilots to production
2024	Sanskriti THAKUR	World economic Forum Strategy Council	Chairwoman, Generational health Pioneer	Modi Prix Galien India	Generational health is not possible without women’s health
2024	Amira GHOUAIBI	World Economic Forum	Head Global Alliance for Women's Health	Modi Prix Galien India	Generational health is not possible without women’s health
2024	Sampada	Astellas Pharma India	General Manager & Managing Director	Modi Prix Galien India	Generational health is not possible without women’s health
2024	Aishwarya RAVI	Pfizer	Pharmaceutical Scientist	Modi Prix Galien India	Generational health is not possible without women’s health
2024	Niveditha	Egon Zehnder	Lead of Healthcare/Life Sciences Pratice	Modi Prix Galien India	Generational health is not possible without women’s health
2024	Krishna SARMA	Corporate Law Group	Managing Partner	Modi Prix Galien India	Addressing pandemics through partnerships
2024	Thomas CUENI	International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)	Director General	Modi Prix Galien India	Addressing pandemics through partnerships
2024	Sudharshan JAIN	Indian Pharmaceutical Alliance (IPA)	IGBA Representative and Secretary General	Modi Prix Galien India	Addressing pandemics through partnerships
2024	Vignesh SHIVNATH	Dr Reddy’s Laboratories	Director, Business Development & Alliance Managemen	Modi Prix Galien India	Addressing pandemics through partnerships
2024	Jasdeep Singh SOOD	Jubilant Pharma, Generics	SVP, President	Modi Prix Galien India	Addressing pandemics through partnerships
2024	Rajinder SURI	Developing Countries Vaccine Manufacturers Network (DCVMN)	CEO	Modi Prix Galien India	Addressing pandemics through partnerships
2024	Stuti JALAN	Crosshairs & Women Inspiring	Founder, Storyteller \| Curator & Speaker Tedx	Modi Prix Galien India	The next frontier in global medicine: advancements in medicine
2024	Shuchin BAJAJ	Ujala Cygnus Hospitals	Founder Director	Modi Prix Galien India	The next frontier in global medicine: advancements in medicine
2024	Pushpanjali R. CHAWLA	Pivotul Consulting Services	Founder	Modi Prix Galien India	The next frontier in global medicine: advancements in medicine
2024	Shailja MITTAL	Qurex	Co-Founder	Modi Prix Galien India	The next frontier in global medicine: advancements in medicine
2024	Peter PUSHPARAJ	AI Nexus Healthcare India	CEO & Director	Modi Prix Galien India	The next frontier in global medicine: advancements in medicine
2024	Pr Sir Munir Pirmohamed	University of Liverpool	UK Galien Forum Chair; David Weatherall Chair of Medicine, University of Liverpool, Liverpool; NHS Chair of Pharmacogenetics	Galien Forum UK	Introduction
2024	Dr Mel Walker	BioPharma Futures	Life Sciences Strategic Advisor and Managing Director	Galien Forum UK	No decision for me without me: Putting Patients at the heart of drug development
2024	Robyn Bent	FDA	Director of CDER’s Patient-Focused Drug Development (PFDD) Program	Galien Forum UK	No decision for me without me: Putting Patients at the heart of drug development
2024	Dr Sarah Gheuens	Agios Pharmaceuticals	Chief Medical Officer, Head of R&D	Galien Forum UK	No decision for me without me: Putting Patients at the heart of drug development
2024	Dr Maria Mavris	European Medicines Agency	Patient Liaison	Galien Forum UK	No decision for me without me: Putting Patients at the heart of drug development
2024	Elizabeth Vroom	World Duchenne Organization	Co-founder and chair	Galien Forum UK	No decision for me without me: Putting Patients at the heart of drug development
2024	Dame June Raine	Medicines and Healthcare products Regulatory Agency	Chief Executive	Galien Forum UK	Introducing New Technologies: Optimising pathways to improve population health
2024	Pr Gary Ford	ealth Innovation Oxford and Thames Valley	Chief Executive Officer	Galien Forum UK	Introducing New Technologies: Optimising pathways to improve population health
2024	Hilary Hutton-Squire	Gilead Sciences	Vice President, Head of Global Value and Access	Galien Forum UK	Introducing New Technologies: Optimising pathways to improve population health
2024	Sir Harpal Kumar	BioPharma Business & Europe, GRAIL, LLC	President	Galien Forum UK	Introducing New Technologies: Optimising pathways to improve population health
2024	Dr Hakim Yadi	Closed Loop Medicine	CEO	Galien Forum UK	Introducing New Technologies: Optimising pathways to improve population health
2024	Dr Miles Congreve	Isomorphic Labs	Chief Scientific Officer	Galien Forum UK	Can we use artificial intelligence to design new drugs?
2024	Lord Prior of Brampton		Deputy Chairman UK and Global Senior Advisor at Lazard, Chairman of Protas; Chairman of the Cambridge Life Sciences Council and Chairman of Tympa Health	Galien Forum UK	Innovation in R&D: The Birth of Breakthroughs
2024	Tamsin Berry	Population Health Partners	Co-founder and partner	Galien Forum UK	Innovation in R&D: The Birth of Breakthroughs
2024	Dr Joep Muijrers	Gilde Healthcare	General Partner	Galien Forum UK	Innovation in R&D: The Birth of Breakthroughs
2024	Dr Matthias Müllenbeck		SVP, Head Global Business Development & Alliance Management	Galien Forum UK	Innovation in R&D: The Birth of Breakthroughs
2024	Dr Jane Osbourn	Alchemab Therapeutics Ltd	CSO	Galien Forum UK	Innovation in R&D: The Birth of Breakthroughs
2024	Dr Vin Diwakar		National Director for Transformation (interim)	Galien Forum UK	Data Driven Medicine: The NHS as a strategic partner in Life Sciences
2024	Dr Michelle Longmire	Medable	CEO and Co-Founder	Galien Forum UK	Data Driven Medicine: The NHS as a strategic partner in Life Sciences
2024	Pr Andrew Morris	University of Edinburgh	Director, Health Data Research UK & Professor of Medicine and Vice Principal Data Science	Galien Forum UK	Data Driven Medicine: The NHS as a strategic partner in Life Sciences
2024	Dr Adrian Rabe	Boehringer Ingelheim Ltd.	Head of RWE Centre of Excellence	Galien Forum UK	Data Driven Medicine: The NHS as a strategic partner in Life Sciences
2024	Richard Stephens	MY data & UK Cancer Research Advocates Forum	Patient partner	Galien Forum UK	Data Driven Medicine: The NHS as a strategic partner in Life Sciences
2024	Ming Tang	NHS England	Chief Data and Analytics Officer	Galien Forum UK	Data Driven Medicine: The NHS as a strategic partner in Life Sciences
2024	Dr Walid AMARA	GHT Grand Paris Nord Est	Cardiologist and Electrophysiologist - Chief Department / Arrythmias Management Team	Galien Forum International	ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
2024	Dr Andrea NATALE	HCA Healthcare	Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, Texas, U.S.A. National Medical Director, Cardiac Electrophysiology	Galien Forum International	ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
2024	Dr Matias NORDABY	Boehringer Ingelheim	Associated Therapeutic Area Head - Cardio-Renal-Metabolic Therapeutic Area	Galien Forum International	ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
2024	Dr Pierre SABOURET	European Atherosclerosis Society Member	President of the National College of French Cardiologists, Senior Researcher at Sorbonne University-Heart Institute-Paris	Galien Forum International	ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
2024	Pr Jean-Marc AYOUBI	Foch Hospital - Simone Veil Faculty of Medicine - Université Paris Saclay	Head of Department Gynaecology-Obstetrics & Reproductive Medicine	Galien Forum International	WOMEN’S HEALTH: FERTILITY PRESERVATION
2024	Pr Attilio DI SPIEZIO SARDO	Napoli	Surgeon specializing in gynecology and obstetrics, and an expert in minimally invasive gynecological surgery,	Galien Forum International	WOMEN’S HEALTH: FERTILITY PRESERVATION
2024	Pr Rene FRYDMAN	Foch Hospital	Obstetrician, Gynecologist - Department of Reproductive Medicine and Obstetric Gynecology	Galien Forum International	WOMEN’S HEALTH: FERTILITY PRESERVATION
2024	Pr Laura RIENZI	University of Urbino., Roma	enior clinical embryologist- Scientific Director GENERA PMA, IVI-RMA Global Research Alliance. Associate Professor	Galien Forum International	WOMEN’S HEALTH: FERTILITY PRESERVATION
2024	Dr Michèle VERSCHOORE		Dermatologist, Skin Scientific Expert, Former Medical Director of L’Oréal	Galien Forum International	WOMEN’S HEALTH: FERTILITY PRESERVATION
2024	Pr Olivier CHOSIDOW	La Pitie-Salpetriere University Hospital - Paris, France / French Society of Dermatology / Chairman of the Infectiology and Sexually Transmitted Infections Working Group (GrIDIST)	Dermatologist	Galien Forum International	WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
2024	Pr Paolo GISONDI	University of Verona, Verona, Italy	Dermatology and Venereology	Galien Forum International	WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
2024	Pr Celeste LEBBE	niversité Paris Cite, AP-HP Dermato-oncology, Cancer Institute APHP Nord Paris Cite, INSERM U976, Saint Louis Hospital, Paris, France	Head of the Dermato oncology Unit	Galien Forum International	WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
2024	Rev Andrea CIUCCI	Vatican	Pontifical Academy for Life	Jerusalem Ethics Forum	ARTIFICIAL INTELLIGENCE AND ETHICS
2024	Pr Mauro FERRARI	University of Washington, Seattle WA, USA	Professor of Pharmaceutics	Jerusalem Ethics Forum	ARTIFICIAL INTELLIGENCE AND ETHICS
2024	Pr Alberto E. TOZZI	Bambino Gesù Children’s Hospital, Roma, Italy	Pediatrician and Epidemiologist	Jerusalem Ethics Forum	ARTIFICIAL INTELLIGENCE AND ETHICS
2024	Pr Arnold MUNNICH	Foch Hospital	Geneticist, Department of Reproductive Medicine and Obstetric Gynecology	Jerusalem Ethics Forum	GENE THERAPY
2024	Dr William MEZZANOTTE	CSL	Executive Vice President, Head of R&D	Jerusalem Ethics Forum	GENE THERAPY
2024	Pr Giuseppe NOVELLI	Dipartimento di Oncoematologia, Rome	Direttore U.O.C. Laboratorio Genetica Medica	Jerusalem Ethics Forum	GENE THERAPY
2024	Pr Michaela SEMERARO	Necker hospital - Paris, France	Pediatrician specialized in Gene Therapy and Immunology, responsible of the Center of Clinical Investigation	Jerusalem Ethics Forum	GENE THERAPY
2024	Dr Filippo SURACE	Gruppo Surace	Serial Entrepreneur, Surgeon, Inventor, Founder and CEO of Cube Labs, CEO	Jerusalem Ethics Forum	BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
2024	Dr Işıl GüNEY	Ulysses Advisory Group	Molecular Biologist, Partner BioScience Managers, Partner and Co-founder	Jerusalem Ethics Forum	BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
2024	Yossi BORNSTEIN	Israel Life Science	CEO and Founder of Shizim Group, Founder	Jerusalem Ethics Forum	BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
2024	Dr Chris HENTSCHEL		Molecular Biologist, Former CEO of Medicines for Malaria Venture, Former CEO of MRC Collaborative Center, Former CSO of Centocor	Jerusalem Ethics Forum	BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
2024	Mario MARAZZITI	Italian Parliament	Italian Politician and Journalist, Member of Italian Parliament, Human Rights Leader, Health Diplomacy Leader, Community of Sant’Egidio	Jerusalem Ethics Forum	BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
2024	Satish MODI		Chairman Modi Global Enterprises, Chairman Gujar Mal Modi Science Foundation, Philanthropist, Author	Jerusalem Ethics Forum	BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
2024	Dr Philippe DOUSTE BLAZY	United Unions Fund Unitlife	Chair of the United Unions Fund Unitlife, Former French Minister of Health, Culture and Foreign Affairs, Professor of Public Health, cardiologist	Jerusalem Ethics Forum	ETHICAL CHALLENGES IN LIFE SCIENCES
2024	Michael Rosenblatt	Bain Capital Life Sciences and Flagship Pioneering	Galien Forum Co-Chair; Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan); Advisory Partner, Ascenta Capital; Senior Advisor	Galien Forum USA	OPENING REMARKS
2024	Phillip A. Sharp	MIT	Nobel Laureate; Galien Forum Co-Chair; Institute Professor and Professor of Biology Emeritus, Koch Institute for Integrative Cancer Research	Galien Forum USA	OPENING REMARKS
2024	Julie Louise Gerberding	Foundation for the National Institutes of Health	President and Chief Executive Officer	Galien Forum USA	WOMEN’S HEALTH / GENERATIONAL HEALTH
2024	Diana W. Bianchi	NIH	Director, Eunice Kennedy Shriver, National Institute of Child Health and Human Development	Galien Forum USA	WOMEN’S HEALTH / GENERATIONAL HEALTH
2024	Mary-Ann Etiebet	Vital Strategies	President and Chief Executive Officer	Galien Forum USA	WOMEN’S HEALTH / GENERATIONAL HEALTH
2024	Elizabeth I. O. Garner	American Medical Women’s Association	Former Chief Scientific Officer, Ferring US; Immediate Past President,	Galien Forum USA	WOMEN’S HEALTH / GENERATIONAL HEALTH
2024	Sandra Milligan	Organon	President, Aspira Women's Health	Galien Forum USA	WOMEN’S HEALTH / GENERATIONAL HEALTH
2024	Sans Thakur	TOWER Capital Group and the pioneer of Generational Health	Founder and Chairwoman	Galien Forum USA	WOMEN’S HEALTH / GENERATIONAL HEALTH
2024	Rohit Aggarwala	City of New York	Chief Climate Officer	Galien Forum USA	CLIMATE CHANGE & HEALTH
2024	John Balbus	Office of Climate Change and Health Equity, U.S. Department of Health and Human Services	Deputy Assistant Secretary for Climate Change and Health Equity and Director	Galien Forum USA	CLIMATE CHANGE & HEALTH
2024	Awa Marie Coll-Seck	Republic of Senegal	Chair of the Galien Africa; Former Senior Minister to the President of the Republic of Senegal; Former Minister of Health	Galien Forum USA	CLIMATE CHANGE & HEALTH
2024	Ruxandra Draghia-Akli	INTREPID Alliance	Executive Leader in Life Sciences Innovation and Global Health; Chair of the Scientific Advisory Board,	Galien Forum USA	CLIMATE CHANGE & HEALTH
2024	Jodi Sherman	Yale	Co-Chair, Lancet Commission on Sustainable Healthcare	Galien Forum USA	CLIMATE CHANGE & HEALTH
2024	Ezekiel J. Emanuel	University of Pennsylvania	Vice Provost for Global Initiatives; Co-Director, Healthcare Transformation Institute; Diane v.S. Levy and Robert M. Levy University Professor; Perelman School of Medicine and The Wharton School	Galien Forum USA	BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN
2024	Ariel Katz	H1	Co-founder and Chief Executive Officer	Galien Forum USA	BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN
2024	Daniel Mendelson	JPMorgan Chase & Co.	Chief Executive Officer, Morgan Health	Galien Forum USA	BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN
2024	John M. O'Brien	National Pharmaceutical Council	President and Chief Executive Officer	Galien Forum USA	BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN
2024	Janet Woodcock	U.S. Food & Drug Administration	Former Principal Deputy Commissioner	Galien Forum USA	BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN
2024	Joel S. Marcus	Alexandria Summit	Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Co-Founde	Galien Forum USA	IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE
2024	Lynne Zydowsky	Alexandria Summit	Chief of Science, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; President & Co-Founder	Galien Forum USA	IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE
2024	Steve Harr	Sana Biotechnology	President and Chief Executive Officer	Galien Forum USA	IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE
2024	Thomas J. Lynch Jr.	Fred Hutchinson Cancer Center	President and Director, Raisbeck Endowed Chair	Galien Forum USA	IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE
2024	Priya Singhal	Biogen	Executive Vice President, Head of Development	Galien Forum USA	IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE
2024	Michael Rosenblatt	Bain Capital Life Sciences and Flagship Pioneering	Galien Forum Co-Chair; Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan)Advisory Partner, Ascenta Capital; Senior Advisor	Galien Forum USA	EXCLUSIVE FIRESIDE CHAT FEATURING NOUBAR AFEYAN, CEO OF FLAGSHIP PIONEERING
2024	Noubar Afeyan	Moderna	Founder and Chief Executive Officer, Flagship Pioneering and Co-founder & Chairman	Galien Forum USA	EXCLUSIVE FIRESIDE CHAT FEATURING NOUBAR AFEYAN, CEO OF FLAGSHIP PIONEERING
2024	Kenneth C. Frazier	General Catalyst	Prix Galien Committee Chair (Categories: Medtech, Digital Health, IAE and Startup); Retired Chairman and Chief Executive Officer, Merck & Co., Inc.; Chairman, Health Assurance Initiatives	Galien Forum USA	TRIBUTE TO BERNARD POUSSOT FOLLOWED BY AWARDS CEREMONY FOR THE CATEGORIES: BEST MEDICAL TECHNOLOGY, BEST DIGITAL HEALTH SOLUTION, BEST INCUBATOR/ACCELERATOR/EQUITY AND BEST STARTUP
2024	Phillip A. Sharp	MIT	Nobel Laureate; Galien Forum Co-Chair; Institute Professor and Professor of Biology Emeritus, Koch Institute for Integrative Cancer Research	Galien Forum USA	BIG BIOTECH - WHERE IS IT GOING?
2024	Ray Dehaies	Amgen	Senior Vice President Global Research Emeritus	Galien Forum USA	BIG BIOTECH - WHERE IS IT GOING?
2024	Pushkal Garg	Alnylam	Chief Medical Officer and Executive Vice President, Development & Medical Affairs	Galien Forum USA	BIG BIOTECH - WHERE IS IT GOING?
2024	Jane Grogan	Biogen	Executive Vice President and Head of Research	Galien Forum USA	BIG BIOTECH - WHERE IS IT GOING?
2024	George D. Yancopoulos	Regeneron	Board Co-Chair, President and Chief Scientific Officer	Galien Forum USA	BIG BIOTECH - WHERE IS IT GOING?
2024	Alan Moses	Joslin Diabetes Center	Independent Pharmaceutical/Biotechnology Consultant; Former Global CMO, Novo Nordisk A/S; Board of Directors	Galien Forum USA	FROM NASH TO MASH
2024	Stephen L. Gough	Novo Nordisk	Global Chief Medical Officer and Senior Vice-President of Global Medical Affairs	Galien Forum USA	FROM NASH TO MASH
2024	Mark Hartman	Eli Lilly and Company	Vice President of Medical, Lilly Research Laboratories	Galien Forum USA	FROM NASH TO MASH
2024	Anthony Hollenberg	Boston University Chobanian and Avedisian School Medicine	President of Boston Medical Center and Professor of Medicine	Galien Forum USA	FROM NASH TO MASH
2024	Jeff McIntyre	Global Liver Institute (GLI)	Vice President, Liver Health Programs,	Galien Forum USA	FROM NASH TO MASH
2024	Ira Tabas	Columbia University Irving Medical Center	Richard J. Stock Professor and Vice-Chair of Research, Department of Medicine	Galien Forum USA	FROM NASH TO MASH
2024	Søren Tullin	Boehringer Ingelheim	Senior Vice President and Global Head of CardioMetabolic Diseases Research	Galien Forum USA	FROM NASH TO MASH
2024	Petra Jantzer	Accenture	Senior Managing Director, Global Life Sciences Lead	Galien Forum USA	CEO PANEL
2024	Michael Rosenblatt	Bain Capital Life Sciences and Flagship Pioneering	Galien Forum Co-Chair; Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan)Advisory Partner, Ascenta Capital; Senior Advisor	Galien Forum USA	CEO PANEL
2024	Noubar Afeyan	Moderna	Founder and Chief Executive Officer, Flagship Pioneering; Co-founder & Chairman	Galien Forum USA	CEO PANEL
2024	John F. Crowley	Biotechnology Innovation Organization (BIO)	President and Chief Executive Officer	Galien Forum USA	CEO PANEL
2024	Chris Viehbacher	Biogen	President and Chief Executive Officer	Galien Forum USA	CEO PANEL
2024	Mikael Dolsten	Pfizer Research & Development	Chief Scientific Officer and President	Galien Forum USA	mRNA VS. GENE THERAPY
2024	Katherine High	CRISPR Therapeutics	Professor Emerita at the Perelman School of Medicine at the University of Pennsylvania; Co-founder, Spark Therapeutics; Board Director,	Galien Forum USA	mRNA VS. GENE THERAPY
2024	Kate Jeffrey	Moderna Inc.	Vice President, Immune Therapeutics and Genomic Sciences, Research & Early Development	Galien Forum USA	mRNA VS. GENE THERAPY
2024	Zhen Li	ADARx Pharmaceuticals	President and Chief Executive Officer	Galien Forum USA	mRNA VS. GENE THERAPY
2024	Kinnari Patel	Rocket Pharmaceuticals	President, Head of Research & Development and Chief Operating Officer	Galien Forum USA	mRNA VS. GENE THERAPY
2024	Isaac Kohane	Harvard Medical School	Marion V. Nelson Professor & Chair, Department of Biomedical Informatics, Editor-in-Chief NEJM AI	Galien Forum USA	ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY
2024	Ajay Gannerkote	Ultrasound	Global President and Head of Siemens Healthineers	Galien Forum USA	ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY
2024	John D. Halamka	Mayo Clinic Platform	President	Galien Forum USA	ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY
2024	Michelle Longmire	Co-founder and Chief Executive Officer	Medable	Galien Forum USA	ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY
2024	Chris Mansi	Viz.ai	Co-founder and Chief Executive Officer	Galien Forum USA	ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY
2024	Erika Stanzl	McKinsey	Digital & Analytics R&D Leader, Life Sciences Practice	Galien Forum USA	ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY

What is happening

Prix Galien USA 2024 Awards Ceremony

Galien Forum USA 2024

Pro Bono Humanun Award 2024

Community

Recognition & Celebration

Education

Fueling the Debate

Find out who has spoken at Galien Foundation
meetings and events

Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.

Community

Recognition & Celebration

Education

Fueling the Debate

What is happening

Prix Galien USA 2024 Awards Ceremony

Galien Forum USA 2024

Pro Bono Humanun Award 2024

Community

Recognition & Celebration

Education

Fueling the Debate

Find out who has spoken at Galien Foundationmeetings and events

Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.

Community

Recognition & Celebration

Education

Fueling the Debate

Find out who has spoken at Galien Foundation
meetings and events